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1CHAPTER 1. INTRODUCTION
This thesis explores statistical issues associated with the analysis of data arising
from microarray experiments and from experiments attempting to identify genes whose
expressions are correlated with a phenotypic trait of interest. We refer to the latter as
pQTL, or phenotypic quantitative trait loci.
Microarrays are a powerful technique for simultaneously measuring the expression
levels of tens of thousands of genes. Microarray experiments can generate a large amount
of information which can then be analyzed to identify differentially expressed genes
under varying biological or environmental stimuli, to carry out genetic mapping studies,
to diagnose disease states and to understand gene regulation and interaction.
While experiments involving mRNAmicroarrays have become common place in large-
scale genomic research, their cost can still be high if a large number of individuals are
included in the experiment. Further, the amount of mRNA available from each indi-
vidual in the study is sometimes not sufficient to be used for analysis by microarray.
In these two instances, researchers might consider pooling mRNA from several individ-
uals and obtaining a microarray for a pooled sample rather than for each individual
in the experiment. Because pooling mRNA is an effective way to reduce experimental
cost or to permit inclusion of individuals even if very small amounts of their mRNA is
available, much has been written about the cost of pooling in terms of information loss
(Kendziorski et al., 2003; Kendziorski et al., 2005; Shih et al., 2004; Zhang and Gant
2005). It has been argued, for example, that pooling mRNA reduces the power with
which we can identify differentially expressed genes (Kendziorski et al., 2003).
2The main objective of this dissertation is to investigate the effect of pooling mRNA
on different types of inferences drawn from genomic experimentation. We focus on three
important types of experiments and on the statistical issues associated with pooling
mRNA in each of them. First, we revisit the work of Kendziorski et al. (2003) and
of Shih (2004), who have discussed the problem of computing the power of statistical
tests when mRNA samples are pooled. We propose a more realistic model for the
observed expression level in the pool that more closely represents the processes followed
in the laboratory. In particular, our model explicitly recognizes that mRNA is pooled
on the original scale, prior to any normalization or transformation. Further, we do not
assume that pooling is perfect and construct our pools with potentially different amounts
of mRNA contributed by each subject. We derive the appropriate F-test to identify
differentially expressed genes under that model, and present formula to analytically
calculate the power of different hypothesis testings.
One other important objective of microarray experiments is identification of genes
whose transcript abundance is correlated with phenotype for a quantitative trait of in-
terest. Here again we investigate the effect of pooling mRNA on the estimate of the
correlation between gene expression and phenotype. We consider two different pooling
strategies. In the first approach, individuals are grouped randomly for mRNA pool-
ing. In the second approach, individuals are first stratified by phenotype and pools of
phenotypically similar individuals are then constructed. In both cases, we assume that
while we can observe the phenotype of every individual in the experiment, we measure
gene expression only for pools. We find that when pools are constructed at random,
the standard Pearson product-moment correlation estimate is nearly unbiased and, de-
pending on the number of pools, compares well to the estimate obtained from individual
data in terms of root mean squared error (RMSE). When individuals are stratified by
phenotype, however, the usual product moment correlation estimate is biased and has
large RMSE relative to the estimate obtained from individual observations. We therefore
3propose a maximum likelihood (ML) estimate of the correlation between gene expression
and phenotype. Further, we derive a likelihood ratio testing approach to identify genes
potentially in the genetic pathway of the phenotypic trait of interest and compare the
performance of the test to a permutation test and to the usual test based on the Fisher
transformation of the correlation coefficient.
Finally, we discuss the effect of pooling mRNA on the accuracy with which we can
identify genes whose transcriptome abundance is associated with a QTL of interest. To
do so, we develop an approach to map eQTL when expression levels are available only
from pooled mRNA and called this approach pQTL mapping. We argue that pQTL
mapping can dramatically reduce the number of microarrays that must be obtained and
also simplify the statistical analyses of the data by focusing only on expression data
relevant to the trait(s) of interest. We simulate an intercross F2 population at genome,
transcriptome and phenome levels to test the validity of pQTL and transcriptome map-
ping. We apply the widely used regression method and the composite method, which
takes account of linkage disequilibrium effects, to compare the empirical power between
pQTL and eQTL transcriptome mapping approaches in identifying trait-related genes.
Our findings suggest that while analyzing data obtained from individuals is always
the best approach (at least in terms of power of tests and performance of estimators of
correlation coefficients) it is possible to devise mRNA pooling strategies that significantly
reduce the cost of experimentation with a modest loss of power or of the accuracy
and precision of the estimates of correlation coefficients or locations of eQTLs. In the
dissertation, we discuss the advantages and disadvantages of various pooling strategies
and propose guidelines to decide between them. We include a review of the relevant
literature within each chapter of this dissertation and describe the organization of the
thesis at the end of this Introduction chapter. We now briefly revisit some fundamental
issues associated with the design and analysis of microarray experiments and with the
problem of mapping QTLs.
41.1 Microarray experiments
1.1.1 Microarray technology
Microarray technology has become a widely used tool to investigate biological prob-
lem at genetic level. It provides a snap shot of the mRNA activities of thousands of
genes in a single experiment, which can be used to study the changes of the whole tran-
scriptome over different experiment conditions or time periods. The different levels of
mRNA are produced by a process called the transcription of DNA, which genes are made
of. The mRNA then may be translated to active proteins, which in turn may control
phenotype traits of interest, cell structure and physiologic state, or the developmental
stage of the organism. Therefore, understanding the pattern change of gene mRNA
levels will gain us a deeper knowledge in identifying the genes which are controlling the
trait of interest.
There are four major steps in performing microarray experiments: RNA prepara-
tion, microarray construction, hybridizations and washing procedure, and image analysis
(Chen et al., 2004). In the RNA preparation step, the mRNA of the samples is first ex-
tracted, and then converted to fluorescent labeled complementary RNA or cRNA. This
labeled cRNA samples are more stable then mRNA samples, and are actually placed on
the microarray to quantify the gene expression level. In microarray construction step,
microarrays can be fabricated using a variety of technologies, including printed filter
arrays, printed glass slide arrays, oligonucleotide Affymetrix arrays and Illunima beads
arrays (Han et al., 2004). On each microarray, there are millions copies of known DNA
sequences (probes), which can match and bind to the RNA from the RNA preparation
step. During the hybridization and washing process, the RNA sample is placed on the
probes spotted microarray for hybridization. The washing process keeps the comple-
mentary binding between probes and RNA, and removes the excess RNA that does not
hybridize to any probe. In the last step, an image analysis process is used to measure
5the strength of fluoresces dye and quantify the mRNA levels as signal intensity values.
1.1.2 The design of microarray experiments
The design of a microarray experiment involves several steps. First, researchers must
decide which microarray platform will be used in the experiment. The number of differ-
ent microarray technologies continues to increase. Technologies available today include
high-density nylon membrane arrays, short oligonucleotide (Affymetix) arrays, bead (Il-
lumina) arrays and others. The choice of other experimental parameters would fall under
the umbrella of traditional design of experiments within a statistical framework. Exper-
imental settings, such as the number of microarrays to include in the experiment, the
allocation of mRNA samples to microarrays, the number of measurements to be obtained
from each microarray, whether to pool or how to pool mRNA from different subjects,
depend on the objectives of the experiment, on the number of subjects available, on the
amount of mRNA available from each subject and also on cost considerations. Several
approaches for the design of microarray experiments have been discussed in the litera-
ture. Some of the designs that have been proposed include optimal experimental designs
(Kerr and Churchill, 2001), reference designs and direct designs (Speed and Yang, 2002),
and factor and time course designs (Glonek, 2004). While it is not possible to recom-
mend one design over others for all possible experimental scenarios, some authors have
highlighted the importance of applying general principles of statistical experimental de-
sign to microarray experiments (Smyth et al., 2002). We do not discuss the problem of
the design of a microarray experiment further in this dissertation except as it refers to
the question of pooling mRNA.
1.1.3 Normalization and statistical analysis of microarray experiments
Expression levels measured from a set of arrays are typically ”pre-processed” prior
to statistical analyses. This pre-processing may include different steps depending on
6the type of microarrays used in the experiment, but typically includes a normaliza-
tion step. The process of normalization consists in (partially) removing any systematic
biases which may arise due to variation across microarrays introduced during the exper-
imental process. The idea is to ameliorate the differences between arrays arising from
technological rather than from biological differences across the slides. The appropriate
normalization approaches vary depending on the microarray platform. For example,
Loess curves and quantile normalization are often used to normalize cDNA arrays (Bol-
stad et al., 2003); MAS 5.0 (Affymetrix, 2001) and robust multiple arrays normalization
are recommended approaches for Affymetrix slides (Irizarry et al., 2003); average and
rank invariant normalization apply to Illumina arrays (Illumina, 2005), and housekeep-
ing genes and spike-in genes are used for other types of special arrays. Most of these
approaches to normalization act globally (on all arrays) and are based on non-linear
methods (Lu, 2004; Geller et al., 2003). Chapter 2 of this dissertation discusses in some
detail the consequences of not properly accounting for the non-linearity of the normal-
ization step when estimating the power of tests to identify differentially expressed genes
using pooled mRNA samples.
Once data have been normalized, the statistical analyses of the data depend on the
objectives of the study. Often, interest centers on identifying genes whose expression
changes under different environmental conditions, in different biological specimens or
during different development stages. Initial methods to identify differentially expressed
genes consisted simply of selecting those genes whose observed expressions exhibited a
two-fold change between different experiment conditions (Chen et al., 1997). This ap-
proach, while simple, has limited usefulness because it does not take into account the
variability of expression within genes. At least in terms of usage, procedures based on the
standard analysis of variance (ANOVA) to estimate expression differences across ”treat-
ments” (e.g., tissues, environmental conditions, time points) are most popular today
(see, e.g., Kerr et al., 2000; Chen et al., 2004). Other inferential approaches, including
7those based on mixed linear models and mixture models have also been proposed (Pan et
al., 2001; Thomas et al., 2001). Several researchers have discussed Bayesian approaches
to estimate model parameters in the standard ANOVA-type models or in models relying
on more general distributional assumptions (Newton and Kendziorski, 2003; Love and
Carriquiry, 2006).
One potential limitation of most statistical approaches proposed for identifying dif-
ferentially expressed genes is that the statistical analyses is carried out on the normalized
data, as if no uncertainties were introduced during the pre-processing step. A more con-
vincing approach would be to jointly model the normalization and the analyses steps
since inferences depend on both. Richardson and and Best (2003) had proposed a
Bayesian hierarchical modeling approach that permits at least partial accounting of the
uncertainties introduced during the pre-processing steps in the final estimates of gene
expression differences. However, much remains to be done in that area.
1.2 Mapping quantitative trait loci
A quantitative trait is a continuous trait (such as height or weight), which is con-
trolled by the polymorphism of DNA sequences. Correspondingly, the region of DNA
that controls the quantitative trait is called a quantitative trait locus (QTL). The num-
ber, effect and location of QTLs explaining variation in the phenotypic trait enable a
deeper understanding of the genetic architecture of a trait. QTL mapping is also fun-
damental to identifying candidate genes underlying a trait. Once a region of DNA is
identified as contributing to a phenotype, that region can be sequenced. The DNA se-
quence of any gene in this region can then be compared to a database of DNA for genes
whose function is already known.
QTL mapping, as the name suggests, is the approach by which we attempt to locate a
QTL on a chromosome. To do so, we make use of genetic markers with known location
8and then test the strength of the association between the markers and the QTL by
considering a number of putative locations for the QTL. This approach then serves to
identify a particular region of the genome that is likely to contain a gene associated
with the trait being assayed or measured. To map QTLs, we first need to develop a
resource population, in which genetic marker locus and putative QTL are in linkage
disequilibrium. Then, Using the polymorphism of the genetic markers and the variation
of the qualitative trait, we fit a statistical model under a set of possible QTL locations
to identify the most likely QTL location.
There are two commonly used QTL mapping approaches: single marker analysis and
regression interval mapping. For single marker analysis, the association between marker
genotype and phenotypic trait is separately evaluated at each marker location. One
limitation of this approach is that the effect and location of QTL are confounded in the
single marker analysis. The regression interval mapping procedure is based on the work
of Haley and Knott (1992). A regression equation is fitted for the effect of a hypothetical
QTL at the position of each marker locus and at regular intervals between the marker
loci. Then, the resulting regression coefficient(s) are evaluated using a likelihood ratio
statistic (LRS) which measures the significance of the coefficient(s). The regression
interval mapping approach can not only separately estimate the QTL effect and location
but also fits coefficients for both additive and dominance effects for the population.
A trait is often affected by more than one quantitative trait locus. Quantitative trait
loci other than the one being mapped are sometimes called ”background” loci. These
background QTL have two effects. Those which are not linked to the QTL being mapped
behave like additional environmental effects (or noise) and reduce the significance of any
association. Those which are linked to the QTL being mapped can bias the estimated
effect and location of that QTL. Zeng (1994) proposed a composite interval mapping ap-
proach to avoid the bias that may result due to the linked QTLs located outside the QTL
interval. Composite interval mapping can be viewed as an extension of regression inter-
9val mapping, and consists in estimating regression coefficients for a target QTL in one
interval while simultaneously estimating partial regression coefficients for ”background
markers” to account for variance caused by non-target QTLs. Therefore, the composite
interval mapping approach is more appropriate when we believe that multiple QTLs
may be present in the chromosomal region of interest.
1.3 eQTL transcriptome mapping
The expression of a gene can be viewed as a quantitative trait, and it is controlled
by the polymorphisms in that or other genes. Therefore, phenotypic QTL mapping can
be applied in gene expression data to identify the QTL which control gene expression
levels. Jansen and Nap (2001) proposed integrating global gene expression analysis with
QTL mapping in a multi-factorial manner, to allow simultaneous analysis of multiple
QTL. In this approach, here called eQTL transcriptome mapping, subjects in a QTL
mapping population (e.g. an F2 cross) are individually evaluated for global gene ex-
pression and genotyped for markers across the genome. Then, standard QTL mapping
methods are used to identify QTL (expression QTL, eQTL) that control variation in
the level of expression of individual genes by considering expression of a given gene as
a quantitative phenotype. This analysis identifies regions of the genome that harbor
genes that control transcription levels of a gene or genes. eQTL transcriptome mapping
bridges the gap between genome sequence variation and phenotypic variation by the
analysis of transcriptome RNA variation.
When an eQTL encompasses the physical location of the genes for that transcript,
it is likely that the causative genetic variation resides within the gene itself (i.e., the
transcript is being regulated in cis, and the corresponding QTL is called a cis-QTL). On
the other hand, if an eQTL does not encompass the physical location of the gene for that
transcript, the transcript is trans-regulated and the corresponding eQTL is called a trans-
10
QTL. Jansen (2003) provides hypothetical results of an eQTL mapping experiment to
explain the relationship between cis and trans eQTLs (Figure 1.1, adapted from Jansen,
R.C. 2003 Nature Reviews Genetics). The cis and trans eQTLs either up-regulate (red)
or down-regulate (green) the expression level of the corresponding transcripts.
Figure 1.1 The hypothetical relationships between cis eQTL and trans
eQTL in eQTL transcriptome mapping
As confirmed in several experiments (Brem et al., 2002; Pomp et al., 2004; Yvert et
al., 2004; Gibson and Weir 2005), most trait-associated gene expression differences are
trans-acting and not caused by a polymorphism in the gene itself but by polymorphism at
an eQTL in other parts of the genome. However, the effects of trans-eQTL are generally
much smaller than those of cis-eQTL (Schadt et al., 2003). Differentially expressed genes
that are associated with cis-acting eQTLs are important candidate genes for the eQTL
11
(Doss et al., 2005).
eQTL transcriptome mapping is an effective approach to understand the genetic
regulation of a phenotypic trait of interest. However, it is relatively expensive due to
the large number of individual microarrays that must be obtained to guarantee sufficient
statistical power. In addition, the eQTL transcriptome mapping can point not only to
the differentially expressed genes and to the eQTL associated with the trait of interest
but also to other eQTLs not related to the phenotypic trait of interest. Thus, statistical
methods that permit identifying only genes and eQTLs of interest are needed (Schadt
et al., 2003, Drake et al., 2006).
1.4 Thesis organization
This dissertation is organized in the form of three manuscripts, proceeded by an
introduction chapter and followed by a general discussion chapter.
Chapter 2 is a manuscript that has been submitted to Bioinformatics for possible
publication. In the chapter, we propose an improved statistical model and analysis
method to identify differentially expressed genes in designs that include mRNA pooling.
Several studies have investigated the impact of pooling mRNA on inferences about gene
expression, but have typically modeled the process of pooling as if it occurred on the
transformed scale (Kendziorski et al., 2003; Kendziorski et al., 2005; Shih et al., 2004;
Zhang and Gant 2005), which is unrealistic. We build a statistical model for observed
expression in the pool by assuming that mRNA samples are pooled on the original scale.
Further, the model takes into account the additional variability that may arise when
pools do not include exactly the same mRNA amount for all individuals. We develop
the appropriate F statistic to test for differentially expressed genes, and present formulae
to calculate the power of various statistical tests under different strategies for pooling
mRNA.
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Chapter 3 is a manuscript to be submitted, in which we develop a maximum likeli-
hood estimator (MLE) to estimate the true correlation between gene expression levels
and trait phenotype in microarray experiments with mRNA pooling. We consider two
pooling strategies (at random, or stratifying individuals by phenotype) and evaluate the
performance of the standard Pearson product-moment correlation estimate and of the
MLE proposed where relative to their performance when microarrays are obtained for
each sample individual. Via simulation studies, we compare the Pearson correlation co-
efficients and MLE in terms of bias and precision for individual, random and stratified
pool designs. We also apply the MLE in a likelihood ratio test to determine whether
gene expression level is truly correlated with phenotype, and compare the empirical
power of the likelihood ratio test to a permutation test and the test based on Fisher’s a
transformation under both pooling strategies.
Chapter 4 consists of the third manuscript to be submitted. In this Chapter we fo-
cus on pQTL transcriptome mapping and evaluate its power relative to the power that
can be achieved with eQTL transcriptome mapping for identifying genes and pathways
that contribute to variation in the phenotypic trait. eQTL transcriptome mapping is an
approach that combines QTL mapping and microarray technology, and has been shown
to be promising in dissecting gene regulation networks (Brem et al., 2002). However, the
high cost of microarrays tends to limit the power and application of eQTL transcriptome
mapping. The pQTL mapping approach is based on eQTL transcriptome mapping and
pools of mRNA samples. To carry out pQTL mapping, individuals are first stratified
according to the QTL genotype. Individuals in each genotypic group are then randomly
allocated to pools. Gene expression levels are measured in the pools rather than in-
dividuals. Via simulation studies, we evaluate the efficiency of pQTL transcriptome
mapping approach in identifying trait related genes. Further, we compare the empirical
power between eQTL and pQTL transcriptome mapping approaches by the regression
and composite methods.
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Finally, Chapter 5 includes a brief summary of the findings in this work and a general
discussion that ties the three manuscripts together. The unifying theme running across
the three major chapters in the dissertation is the impact of pooling mRNA on inferences
about different quantities of interest in microarray and mapping experiments. In the
discussion, we integrate our findings into general recommendations for designing and
analyzing microarray experiments that involve pooling mRNA samples.
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CHAPTER 2. POOLING mRNA IN MICROARRAY
EXPERIMENTS AND ITS EFFECT ON POWER
A paper submitted to Bioinformatics
Wuyan Zhang, Alicia Carriquiry, Dan Nettleton, and Jack C.M. Dekkers
Abstract: Microarrays can simultaneously measure the expression levels of many genes
and are widely applied to study complex biological problems at the genetic level. To
contain costs, instead of obtaining a microarray on each individual, mRNA from several
subjects can be first pooled and then measured with a single array. mRNA pooling is
also necessary when there is not enough mRNA from each subject. Several studies have
investigated the impact of pooling mRNA on inferences about gene expression, but have
typically modeled the process of pooling as if it occurred in some transformed scale. This
assumption is unrealistic. We propose modeling the gene expression levels in a pool as
a weighted average of mRNA expression of all individuals in the pool on the original
measurement scale, where the weights correspond to individual sample contributions
to the pool. Based on these improved statistical models, we develop the appropriate
F statistics to test for differentially expressed genes. We present formulae to calculate
the power of various statistical tests under different strategies for pooling mRNA and
compare resulting power estimates to those that would be obtained by following the
approach proposed by Kendziorski et al. (2003). We find that the Kendziorski estimate
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tends to exceed true power and that the estimate we propose, while somewhat conserva-
tive, is less biased. We argue that it is possible to design a study that includes mRNA
pooling at a significantly reduced cost but with little loss of information.
KEY WORDS: mRNA pooling; Microarray; Power.
2.1 Introduction
Microarray experiments are widely used to measure the expression levels of tens
of thousands of genes simultaneously under different experimental conditions or during
different time periods. One of the major interests in microarray experiments is to identify
genes which are differentially expressed between conditions or time periods, and enable
a deeper knowledge of complex biological problems at the genetic level. However, the
unit cost of microarrays continues to be high; even for a moderate number of subjects,
cost can be significant. One option to control costs is to pool the mRNA of a group
of individuals and then run microarrays on the pools rather than on each individual.
Pooling mRNA may also be required when there is not enough mRNA from each subject
to hybridize individual microarrays.
The effect and efficiency of pooling mRNA in microarray experiments have been
investigated by several researchers. Kendziorski et al. (2003) showed that pooling is most
advantageous when biological variability (variability across subjects) in expression level
is larger than technical variability (variability introduced in the experimental process).
They also derived a formula for the total number of arrays and individuals required in an
experiment involving mRNA pools to obtain gene expression estimates and confidence
intervals comparable to those that would be obtained when analyzing individual arrays.
They concluded that by increasing the total number of individuals in the experiment,
it was possible to maintain precision of estimates by pooling, while decreasing the total
number of arrays. Shih et al. (2004) also discussed the impact of pooling mRNA on the
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power of statistical tests. They derived an expression to carry out power calculations for
a given number of arrays and individuals. Further, they used expression data obtained
from mice to check the adequacy of the assumption that mRNA expression levels in the
pool are close to the average expression levels of individuals in the pool. They showed
that the assumption does not hold, especially when the signals are high.
Both Kendziorski et al. (2003) and Shih et al. (2004) derived their results on the
transformed scale, that is, after the data were normalized and signal intensity was
transformed. Thus, both studies assumed that the mRNA expression in the pool is
the average expression of individual samples, and applied the assumption on the trans-
formed scale. This assumption is however not realistic in a biological sense because in
the laboratory, the mRNA is extracted from samples and then mixed to form an mRNA
pool. Therefore, pooling occurs on the original scale and an assumption that holds on
the transformed scale may not hold before transformation.
In this paper, we address the issue of testing for differences in gene expression across
treatments. We assume that the expression level in a pool is approximately equal to the
average expression of individuals in the pool on the original scale. More precisely, we
assume that the expression level in a pool is a weighted average expression of individual
samples on the original scale, where weights correspond to the proportional contribution
of each individual to the pool. By including the weights in the average, we account
for the fact that in the process of combining individual mRNA samples, the mixing
proportions may not be identical and thus, that the pool may contain more mRNA from
some individuals than from others.
Under the assumptions above, we derive expressions to calculate power under differ-
ent treatment effect sizes, number of mRNA pools, number of individuals per mRNA
pool, and number of repeated measurements per pool. We wish to understand how much
power is lost by pooling mRNA. We also wish to find efficient experimental designs for
pooling mRNA samples, while keeping costs down.
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2.2 Methods
2.2.1 Notation and model
Microarray gene expression measurements tend to be right skewed and thus not
normally distributed. Therefore, data are usually transformed and normalized before
statistical analysis. The most common transformation is the log transformation (Geller
et al., 2003). The transformed data can then be modeled as a linear function of treat-
ment effects and one or more normally distributed random effects (Lu 2003, Shih et
al., 2004, Han et al., 2004 ). The sources of variation in a microarray experiment are
multiple and can be generally classified into two groups: biological variation and tech-
nical variation (Kendziorski et al., 2003 and Chen et al., 2004). Biological variation is
subject-to-subject variation in gene expression and is due to subject-specific genetic or
environmental factors. Technical variation arises from the errors that can potentially be
introduced at each of multiple steps in a microarray experiment. These include RNA
sample preparation, microarray construction, hybridization and washing procedures and
signal detection methods. Here, we focus on the two major categories: biological varia-
tion and technical variation.
The expression levels of tens of thousands of genes are measured simultaneously in
a microarray experiment. For simplicity of notation, a single gene is considered in the
following derivation and analysis. The true gene expression level of a gene on the jth
individual in the ith treatment is denoted mij and can be modeled on the log scale as
log(mij) = µi + ²ij, (2.1)
i = 1, 2, ..., T , j = 1, 2, ..., N . Here, T is the number of treatments (or conditions), N is
the number of individuals per treatment, µi is the mean gene expression level for the i
th
treatment , and ²ij is biological error which is assumed to be independently, identically
distributed as N(0, σ2b ). We use σ
2
b to denote the biological variance in gene expression.
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Then, the observed gene expression level oij in log scale can be modeled as
log(oij) = µi + ²ij + ξij = log(mij) + ξij, (2.2)
where ξij is technical error which is also assumed to be independently, identically dis-
tributed as N(0, σ2t ). Biological and technical errors are assumed to be independent.
Suppose now that the mRNA from n subjects from the same treatment is combined
to form a pool. We use mpij to denote true expression for a gene in the i
th treatment
group and jth pool. We assume that the true expression level of a gene in the mRNA
pool is a weighted average of the true expression levels of the gene in all individuals in
the same mRNA pool, so that
mpij =
n∑
k=1
(wijk ∗mijk), (2.3)
where
wijk =
zijk
zij1 + zij2 + ....+ zijn
,
i = 1, 2, ..., T , j = 1, 2, ..., P , k = 1, 2, ..., n. Here, P is the number of mRNA pools per
treatment and n is the number of individuals per mRNA pool. Therefore, P ∗ n = N ,
where N denotes the total number of individuals per treatment group in the experiment.
When n = 1, the experiment involves no mRNA pooling (a microarray is made for each
individual). The random unobservable weight wijk represents the relative contribution of
individual k to pool j in treatment i. We write the weights as functions of the zijk, which
denote the technical deviations from the ideal pool containing equal amounts of mRNA
from each individual sample. We assume that the zijk are independently, identically
distributed as N(1, σ2z), where σ
2
z denotes the pooling technical variance. If we denote
the observed mRNA level in a pool by opijl we can then model it on the log scale as:
log(opijl) = log(m
p
ij) + ξijl, (2.4)
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where ξijl is technical error as defined earlier and l = 1, 2, ...R. Here, R is the number
of replicated array measurements per pool and R ∗ P = A, where A is the total number
of arrays per treatment group. P = A if each mRNA pool is measured only once. Note
that model (2.4) for the transformed observed mRNA level in a pool is similar to model
(2.2) formulated for observed mRNA in an individual array on the transformed scale.
2.2.2 Expectation and variance of log(mpij)
The distribution of log(mpij) is analytically intractable, but simulations and goodness-
of-fit testing show that it can be well approximated by a normal distribution. We will
use µpi and σ
p2
b to denote the mean and variance of this normal distribution. We can
then write
log(mpij) ≈ µpi + τij (2.5)
and
log(opijl) ≈ µpi + τij + ξijl, (2.6)
where τij is assumed to be independent and identically distributed N(0, σ
p2
b ).
We are interested in testing for differences in gene expression across treatments of
the form µi − µj. In this subsection, we will derive expressions for µpi and σp2b and show
that µi − µj = µpi − µpj so that the tests of interest can be conducted using data from
pools.
To derive expressions for µpi = E[log(m
p
ij)] and σ
p2
b = Var[log(m
p
ij)], we expand
log(mpij) using a Taylor series to obtain
log(mpij) = log(ν
p
i ) +
∞∑
k=1
(−1)k−1(mpij − νpi )k
k(νpi )
k , (2.7)
where νpi = E(m
p
ij). Then, the second order approximation to µ
p
i is given by
µpi = E[log(mijp)] ≈ log(νpi )−
σp2i
2νp2i
, (2.8)
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where σp2i denotes the variance of m
p
ij. In the Appendix, we show that
νpi = E(m
p
ij) = e
µi+σ
2
b/2 (2.9)
and
σpi
2 = Var(mpij) =
1
n
(e2µi+2σ
2
b − e2µi+σ2b )(1 + n2σ2w). (2.10)
where σ2w is the variance of weights wijk. Using these expressions, it is easily seen that
the expectation of the second order term in the Taylor expansion is free of µi; i.e.,
σpi
2
2νpi
2 =
1
2n
(eσ
2
b − 1)(1 + n2σ2w). (2.11)
Similarly, it can be shown that higher order terms are also free of µi, which facilitates
the comparison of hypothesis testing results between designs that involve pooling and
those that do not.
Applying the delta method, we find:
σpi
2 ≈ 1
n
(e2µi+2σ
2
b − e2µi+σ2b )(1 + n− 1
n
σ2z). (2.12)
Therefore, substituting expressions (2.9) and (2.12) into expression (2.8), we obtain:
µpi = E[log(m
p
ij)] ≈ µi +
σ2b
2
− 1 +
n−1
n
σ2z
2n
(eσ
2
b − 1). (2.13)
If we apply the delta method again, we get
σpb
2 = Var[log(mpij)] ≈
n− 1
n2
σ2z +
1
n
(eσ
2
b − 1). (2.14)
We now note that the random effect τij in model (2.6) is an error term attributable to
biological variation in expression level and to the additional variability that is introduced
when pooling mRNA samples.
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2.2.3 Power in a design that includes pooling mRNA
One interesting finding is that µpi − µpj = µi − µj, because from expressions (2.7)
and (2.13), we see that µpi − µi is a constant (free of µi) across all treatment groups.
Therefore, the hypothesis for testing : µp1 = µ
p
2 = ... = µ
p
T in the design that includes
pooling is equivalent to the hypothesis that would be used for testing µ1 = µ2 = ... = µT
in a design that involves individual microarrays. The corresponding F test statistic for
the design with pooling is given by
F =
∑T
i=1 P (log(o
p
i..)− log(op...))2
T − 1
∑Ti=1∑Pj=1(log(opij.)− log(opi..))2
T ∗ (P − 1)
−1 . (2.15)
The null hypothesis of no treatment differences is rejected at significance level α if the
F statistic is larger than FT−1,T∗(P−1),α, where Fdf1,df2,α is the (1− α) ∗ 100th percentile
of a central F-distribution with df1, df2 degrees of freedom.
If the type I error is controlled at level α, power of the test is given by
1− β = Pr(FT−1,T∗(P−1)(δ2) > FT−1,T∗(P−1),α), (2.16)
with noncentrality parameter δ2, where
δ2 =
P
∑T
i=1(µ
p
i − µp)2
σpb
2 + 1
R
σ2t
≈ P
∑T
i=1(µ
p
i − µp)2
n−1
n2
σ2z +
1
n
(eσ
2
b − 1) + 1
R
σ2t
, (2.17)
with P and R as defined earlier and µp is the mean of µpi across treatments.
For a more general test of hypothesis for a linear combination of the means: Cµp = d
where µp = (µp1, µ
p
2, ..., µ
p
T )
t with C a known matrix of constants with full rank r, power
is calculated as
1− β = p(Fr,T∗(P−1)(δ2) > Fr,T∗(P−1),α), (2.18)
where the noncentrality parameter is given by
δ2 =
P
σpb
2 + 1
R
σ2t
(Cµp − d)t(CCt)−1(Cµp − d). (2.19)
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2.3 Results
2.3.1 Comparing estimates of power
Expressions (2.16) and (2.18) to calculate the power of a test of hypothesis for dif-
ferences between means are based on an assumption of normality and rely on Taylor
approximations. To estimate the impact of these two approximations, we simulated
data and calculated power numerically and using the analytical expressions derived in
Section 2.2.3. We also compared power from simulation with power calculated analyti-
cally under the Kendziorski model (Kendziorski et al., 2003).
We simulated individual data under two different scenarios. For the first scenario, we
fixed the number of treatment groups at three (T = 3) and the number of individuals per
treatment group at 100 (N = 100). The mean expression difference between adjacent
treatment groups on the log scale (µ1−µ2 = µ2−µ3) was assumed to be 0.2, 0.3, 0.4, or
0.5. Biological and technical variances were fixed at 0.75 and 0.25 (σ2b = 0.75, σ
2
t = 0.25),
respectively. Pooled data under our model were simulated as a weighted average of five
or three individuals (weight variation was σ2z = 0.05
2) on the original scale. Therefore,
n = 5 and we considered 20 pools per treatment (P = 20). For the second scenario, we
simulated less individuals and less pools with N = 15, n = 3 and P = 5 while keeping all
the other parameters the same. For each scenario, a one-way ANOVA model was fitted
to the simulated pooled data to test whether the mean expression level was different
across treatment groups. We compared the power of the tests at α = 0.05. Results are
presented in Table 2.1. Power calculated by simulation was based on 10000 replicates of
the experiment. The entries in the column labeled “Analytical power” were calculated
under two different models: the proposed model (expression 2.6) and the Kendziorski
model (Kendziorski et al. 2003).
In both scenarios, the predicted power as computed using the approach proposed
by Kendziorski et al. (2003) appears to be overly optimistic in that it consistently ex-
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Table 2.1 Power of the test for treatment difference computed numerically
by simulation and analytically by the proposed model and the
Kendziorski model
Mean expression Power calculated Analytical power
difference by simulation Proposed model Kendziorski model
N=100,n=5,p=20
0.2 0.383 0.341 0.386
0.3 0.684 0.669 0.739
0.4 0.909 0.904 0.955
0.5 0.991 0.985 0.997
N=15,n=3,p=5
0.2 0.089 0.090 0.101
0.3 0.159 0.145 0.169
0.4 0.252 0.226 0.274
0.5 0.379 0.334 0.405
ceeds power calculated from simulation. This may be because their approach does not
account for the additional variance introduced in the pooling step and because they
assume that mRNA samples can be pooled on the log scale directly. If we let σ2z equal
to zero while keep all the other parameter unchanged as in the first scenario and cal-
culate power again by simulation, we find that the power estimates are 0.383, 0.682,
0.906 and 0.987, which are very close to the power when σ2z = 0.05
2. Therefore, the
additional variance introduced in the pooling step does not affect power much, and the
assumption that pooling mRNA can happen on log scale is the leading factor causing
the overestimation in Kendziorski model. On the other hand, the power computed using
the analytical expression in Section 2.2.3 is conservative because our estimate for the
variance is conservative. Therefore, true power is at least high as our predicted power.
2.3.2 The effect of repeated measurements on power
For a given set of experimental conditions, biological, technical and weight variation
in the pooled data are often fixed. Therefore, the power of the test for a given set
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of conditions depends on the number of pools, the number of repeated measurements
per pool and the number of individuals per pool. Consider the following example:
suppose that there are three treatment groups (T = 3) and 100 individuals per treatment
(N = 100), and let the mean expression difference between any two adjacent treatment
groups on the log scale be 0.5 (µpi −µpj = 0.5), which represents a 1.65 fold difference on
the original scale. Suppose that total variation is equal to 1, biological variance is three
times as large as technical variance (σ2b = 0.75 and σ
2
t = 0.25), and technical standard
deviation in the pooling step is 5% of the standardized mean (σ2z = 0.05
2). Then,
for a fixed number of arrays per treatment (A = 5, 10, 15, 20), the effect of obtaining
repeated measurements on each pool on power is shown in Figure 2.1. We computed
power analytically using expression (2.16) with any R and P values that match the
equation R ∗P = A. Note, however, that R and P will always have integer values in an
actual experiment. Power decreases as the number of repeated measurements per sample
increases for fixed numbers of individuals and arrays. Therefore, when the number of
subjects is fixed and the number of arrays is limited, a more efficient strategy is to create
multiple pools and measure each once rather than to create fewer pools and measure
each multiple times. This is consistent with findings in Kendziorski et al. (2003). In the
remainder, we assume that each pool is measured once (R = 1, P = A).
2.3.3 The effect of the number of mRNA pools on power
Figure 2.2 shows power that is computed using expression (2.16) when different
numbers of pools are created under various mean expression differences between adjacent
treatments (µpi − µpj = 0.2, 0.3, 0.4, 0.5). For a fixed number of individuals, the power
of the test based on individual samples is always higher than when samples are pooled,
as would be expected. Power increases as the number of pools increases, and it is
maximized when P = N , i.e., when we microarray each individual. The rate at which
power increases with mean expression difference is relatively high when the number of
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Figure 2.1 The effect of repeated measurement on power for
different total numbers of arrays per treatment:
T = 3, N = 100, µpi − µpj = 0.5, σ2b = 0.75, σ2t = 0.25, σ2z = 0.052
and A = 5, 10, 15, 20.
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pools is small, but relatively low when the number of pools is relatively large. When
the number of pools is large enough (30 or higher, approximately) we observe no further
increase in the power. For example, under µpi − µpj = 0.4, power increased by 0.2, 0.05
and 0.005 when P increased from 10 to 20, from 20 to 30 and from 50 to 60. The
almost flat trend is especially obvious when the mean expression difference is larger
(µpi − µpj = 0.4, 0.5). The slow or almost flat trend in the power curve makes it possible
to find a pooling design with power that approaches the power that can be achieved with
individual arrays and at the same time control costs. For example, when n changes from
1 to 2 (individual arrays vs. pools of two individuals per sample), power dropped from
0.9999 to 0.9993, from 0.994 to 0.982 and from 0.91 to 0.85 when µpi − µpj = 0.5, 0.4, 0.3.
The higher the power of tests based on individual samples, the higher the number of
individuals that can be pooled together without significant loss of information. For
example, when µpi − µpj = 0.5, a design that involves forming P = 10 pools with n = 10
individuals each has 90% of the power of the design that involves no sample pooling,
and yet the cost of arrays is only 10% of the cost of arraying every individual.
2.3.4 The effect of biological, technical and weight variability on power
From the results presented in Section 2.2.3, we know that power depends on σpb
2
and σ2t , as well as on treatment mean differences and on the number of individuals and
arrays. When biological variance and the variability introduced by the pooling process
are reasonably small, the first term in expression (2.14) is close to 0, and the second
term can be approximated by σ2b/n because e
σ2b − 1 ≈ σ2b . Therefore, σpb 2 can be well
approximated by σ2b/n. Based on the approximation, the ratio of biological variance to
technical variance must be considered. The effect of the ratio of biological to technical
variance on power is shown in Figure 2.3. As would be expected, power in designs that
involve pooling samples increases as the technical variance gets smaller relative to the
biological variance. For example, when the mean expression difference is 0.5 and the
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Figure 2.2 Relationship between number of pools and power for differ-
ent treatment effect sizes µpi − µpj = 0.2, 0.3, 0.4, 0.5 and for
T = 3, N = 100, σ2b = 0.75, σ
2
t = 0.25, σ
2
z = 0.05
2.
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design includes 10 pools of 10 samples each, power increases from 0.72 when σ2b = σ
2
t to
0.92 when σ2b = 4σ
2
t .
Figure 2.3 Relationship between number of pools and power for different
ratios of biological to technical variance σ2b/σ
2
t = 1, 2, 3, 4 and
for T = 3, N = 100, µpi − µpj = 0.4, and σ2z = 0.052.
The additional technical variation introduced in the pooling step does not appear
to affect power much (Figure 2.4), even if the pooling technical variance is rather high
(σ2z = 0.2
2). This is because in the denominator of expression (2.17), σ2z is very small
compared to eσ
2
b − 1 and σ2t . Also the effect of pooling technical variation is further
decreased by the factor n−1
n2
. Therefore, the additional technical variation introduced in
the pooling step is not a major factor to consider in power calculation.
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Figure 2.4 Relationship between number of pools and power for different
pooling technical variance σ2z = 0.01
2, 0.052, 0.12, 0.22 and for
T = 3, N = 100, µpi − µpj = 0.3, σ2b = 0.75, σ2t = 0.25.
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2.4 Discussion
Samples of mRNA from individuals are sometimes pooled in microarray experiments,
either because the biological material available from each individual is not sufficient to
array or to keep costs down. It is to be expected that statistical tests to detect differences
in mean gene expression levels across treatments will be affected when they are based
on pools of mRNA samples rather than on individual samples, since some information
is bound to be lost. In particular, the power of F-tests in the usual ANOVA models
is expected to decrease when the experimental design involves pooling of individual
samples.
Several authors have investigated the statistical properties of F-tests based on pooled
mRNA samples (Kendziorski et al. 2003 and Shih et al. 2004). One limitation in
these studies is that the statistical models adopted imply that the mRNA samples are
pooled on the log scale, which is unrealistic. We investigated the power of F-tests in
ANOVA models when mRNA samples are pooled, but extended the models so that the
pooling process is carried out on the original scale. In our formulation, mRNA pools
are weighted averages of individual mRNA samples and consider the measurement error
that is introduced when pooling potentially different amounts of mRNA from individuals
into a pool. We argue that when pooling is assumed to occur on the log scale, the power
of the tests is over-estimated and propose an approach to calculate power under the
more realistic scenario of pooling on the original scale.
It is not possible to derive an analytical expression for the distribution of pooled
gene expression on the log scale. Therefore, we assume that gene expression on the log
scale is normally distributed. To check this assumption, we conducted simulation studies
and found that, at least for the range common to the microarray data, the normality
assumption appears to be reasonable. Our focus is on deriving expressions to calculate
the power of F-tests to detect mean gene expression difference across treatments in
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designs that involve pooling. Because the F-test is robust to modest departures from
normality (Mendes and Pala, 2004), we anticipate that assuming a normal model for
the gene log-expression values will not have a noticeable effect on our results. We show
that the power estimated using the approach we propose here is conservative in that it
tends to slightly under-estimate true power; therefore, true power is at least as high as
the estimates resulting from implementing the method we propose.
As might be expected, the power of the tests depends not only on the size of the
treatment effect but also on the total number of individuals and pools, the number of
pools per treatment, the number of replicated measurements obtained for each pool, and
the magnitude of biological and technical variability. For the technical variability, we
distinguish the usual variance introduced in the various steps of microarray experiments
and the variability that is introduced during the pooling process, resulting from the
possibly differential contributions of individual samples to the pool.
We used simulated gene expression data to compare the power of F-tests that can be
achieved when analyzing individual mRNA samples and under various pooling designs.
We computed power analytically and also via simulation, and compared results to those
that would be obtained by implementing the approach proposed by Kendziorski et al.
(2003). We found that given a fixed number of individuals and arrays, power tends to
be higher when a larger number of pools is measured once than when replicate mea-
surements are obtained on a smaller number of pools. This holds for all values of the
biological, technical and pooling variabilities considered in our study. Not surprisingly,
we also found that power of tests based on individual samples is always higher than
power based on pooled samples. For large enough effect sizes, however, it is possible
to design an experiment that involves pooling mRNA samples that almost achieves the
power that would be obtained when arraying individual samples, but at a fraction of the
cost. Thus, our results suggest that under some conditions, pooling mRNA samples in
microarray experiments can be a good strategy if cost is a consideration.
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One of the important features of our model is that it attempts to mimic the pooling
process as it happens in the lab. We assume that the mRNA pool is a weighted average
of expression levels from individual mRNA samples, and let the weights be random
variables with zero mean and some variance. Suppose that the mean expression level
of individual j in the ith pool on the original scale is µi. Because the log is a non-
linear transformation, the weighted average of log-transformed individual means will be
different than the log of the weighted averages of individual samples. It can be shown
that the mean expression in the pool, denoted by µpi is higher than the corresponding
weighted average of the log-transformed individual means µi. Letting µi denote the
weighted average of the log-transformed individual means, the difference, which we derive
in Section 2.2.2 is approximated by µpi − µi ≈ σ2b − 1+
n−1
n
σ2z
2n
(eσ
2
b − 1). In the range of
microarray experiment data, σ2b is relatively small, and e
σ2b−1 can be approximated as σ2b .
Therefore, the difference between µpi and µi is approximately equal to (1− 1+
n−1
n
σ2z
2n
)σ2b ,
which is a positive, monotone function of the biological variance. Shih et al. (2004)
assumed in their work that µpi − µi = 0 and then tested this assumption using data
collected in a microarray experiment on mice. They found that the number of genes with
significantly different expression levels across different treatments was higher than would
have been expected by chance; this effect was even stronger when expression levels were
high. Also, Kendziorski et al. (2005) confirmed further that the pools and the average of
individuals were not always in agreement for certain genes and suggested that modeling
the pooling process on the transformed scale could be a possible reason. These results
can be explained well under our model. Since we show that µpi − µi > 0, the 95%
confidence intervals for the difference between mean expression level in the pool and in
individual arrays are not centered at zero. Further, since the difference between the two
means can be approximated by a positive, increasing function of the biological variance,
and the biological variance tends to be positively associated with gene expression levels,
we expect that the shifting of the confidence intervals will be more pronounced when the
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signal is stronger. In addition, confidence intervals that account for the added variance
introduced in the pooling process are somewhat wider. According to our model and to
the results obtained by simulation, the proportion of genes that fall outside the 95%
confidence intervals discussed by Shih et al. (2004) is 0.077, 0.096, 0.101 and 0.151 when
the biological variance is 0.2, 0.4, 0.6 or 0.8, respectively, and the technical variance is
held constant at 0.25. These unexpectedly high proportions can be explained under our
model, which accommodates pooling in the original (rather than in the log) scale.
One other interesting finding is that after log transformation and assuming of nor-
mality, the expected mean expression difference in a design that involves pooling is the
same as in a design without pooling, i.e., µpi − µpj = µi − µj. Thus, a test for the hy-
pothesis that µpi = µ
p
j is equivalent to the test µi = µj, at least when expression data
have been log-transformed. This property might not hold under other transformations,
however.
We have focused on power calculation under designs that pool or do not pool mRNA
when testing expression differences for a single gene. In microarray experiments, tests
involve tens of thousands of genes and the biological variation may differ from gene to
gene. Therefore, designs that involve pooling and that permit reaching a certain power
may be differ between genes due to differences in biological variation across genes. Thus,
finding a single efficient design for pooling mRNA which results in the desired power for
all the genes in the microarray experiment might be a challenge.
Whether to pool individuals and how to pool them to minimize the loss of information
are important issues in microarray experiments. For a fixed total number of individuals
and arrays, a design that includes mRNA pools always leads to smaller power than
a design in which each array corresponds to an individual. Under some conditions,
however, the loss of power is small, and it is possible to find a low-cost design which
almost achieves the power that can be obtained when arraying each individual.
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2.7 Appendix
Expression (2.9) and (2.10) are derived as follows,
νpi = E(m
p
ij)
= E[
n∑
k=1
(wijk ×mijk)]
=
n∑
k=1
E(wijk)× E(mijk)
= eµi+
σ2
b
2
n∑
k=1
E(wijk)
= eµi+
σ2
b
2 ,
σpi
2 = Var
[
mpij
]
= Var
[
n∑
k=1
(wijkmijk)
]
= E
( n∑
k=1
wijkmijk
)2− [E ( n∑
k=1
wijkmijk
)]2
= E
[
n∑
k=1
(wijkmijk)
2
]
+ 2
n∑
k=1
n∑
l>k
E (wijkmijkwijlmijl)
−
[
n∑
k=1
E(wijk)E(mijk)
]2
=
n∑
k=1
[
E(wijk)
2E(mijk)
2
]
+ 2e2µi+σ
2
b
n∑
k=1
n∑
l>k
E(wijkwijl)
−
[
eµi+
σ2
b
2
n∑
k=1
E(wijk)
]2
= e2µi+2σ
2
b
n∑
k=1
E (wijk)
2 + e2µi+σ
2
bE
( n∑
k=1
wijk
)2
−
n∑
k=1
w2ijk

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−e2µi+σ2b
= ne2µi+2σ
2
bE(w2ijk) + e
2µi+σ
2
b
[
1− nE(w2ijk)
]
− e2µi+σ2b
= nE(wijk)
2
(
e2µi+2σ
2
b − e2µi+σ2b
)
= n
[
(Ewijk)
2 + σ2w
] (
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2
b − e2µi+σ2b
)
= n(
1
n2
+ σ2w)
(
e2µi+2σ
2
b − e2µi+σ2b
)
= (
1
n
+ nσ2w)
(
e2µi+2σ
2
b − e2µi+σ2b
)
.
41
CHAPTER 3. THE ESTIMATION OF CORRELATIONS
BETWEEN PHENOTYPE AND GENE EXPRESSION IN
MICROARRAY EXPERIMENTS WITH mRNA POOLING
Wuyan Zhang, Alicia Carriquiry, Dan Nettleton, and Jack C.M. Dekkers
Abstract: Microarrays are used to simultaneously measure the mRNA expression levels
of thousands of genes. In such experiments, mRNA samples are sometimes pooled across
individuals to reduce cost or to increase mRNA volume. We consider the problem of
identifying transcripts whose abundance is correlated with phenotype for a quantitative
trait of interest. We assume that the quantitative trait phenotype has been measured
on all individuals but that cost considerations require us to measure mRNA expression
levels in pools rather than individuals. Therefore, we propose to form disjoint pools
of individuals randomly or stratified by phenotype. To assess the impact of the two
pooling approaches on the accuracy with which we can estimate the correlation, we use
simulated data so that the true correlation between phenotype and genotype is known.
We first simulate phenotype and expression level as bivariate normally distributed vari-
ables. Then we assume that a pool’s measured mRNA expression level is the average of
mRNA expression levels of the individuals in a pool. We find that the Pearson corre-
lation coefficient between a pool’s trait mean and a pool’s measured mRNA expression
level overestimates the true correlation between phenotype and expression level when
pools are stratified by phenotype. Therefore, we propose obtaining a maximum likeli-
hood estimator (MLE) for the correlation between phenotype and expression that is less
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biased. Via simulation studies, we find that this method is effective in both random and
stratified pool designs. Also the MLE from stratified pool designs has higher precision
than the MLE from random pool designs. Furthermore, our MLE can be used in a
likelihood ratio test to determine whether gene expression level is correlated with phe-
notype. We show that the empirical power in the likelihood ratio test is the same as in
a permutation test in both pool designs, and the power in stratified pool designs is gen-
erally higher than in random pool designs. Therefore, maximum likelihood estimation
for stratified pool designs can provide more precise estimation of the correlation, and
has more power to identify trait-related genes. This information is useful to investigate
which genes might be involved in the genetic pathway of the phenotypic trait.
KEY WORDS: mRNA Pooling; Correlation; Power.
3.1 Introduction
Microarray experiments are widely used to measure the mRNA expression levels of
thousands of genes simultaneously. This technique is a useful tool to understand complex
biological problems at the genetic level. One problem of interest is to identify the genes
whose transcript abundances are correlated with a phenotypic trait of interest (Caldwell
et al., 2001, Booth et al., 2005, Qu and Xu, 2006 and Norholm et al., 2006), because
these genes are important candidates to further investigate the genetic regulation and
pathways that underly the phenotypic trait.
However, the unit cost of microarrays continues to be high; even for a moderate
number of subjects, cost can be significant. Thus, instead of obtaining a microarray
for each individual, several authors have proposed designs which involve pooling mRNA
samples to reduce the total number of arrays needed (Kerr et al., 2003; Kendziorski et
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al., 2003; Shih et al., 2004; and Zhang et al., 2006). The design with mRNA pooling
consists of mixing mRNA samples from a group of individuals and then only measuring
the expression level on the pools rather than on each individual. Such a design is also
convenient when there is not enough mRNA to microarray each individual. In the designs
with mRNA pooling, individuals can be either randomly selected to create disjoint pools
(random pool design) or pools can be formed based on phenotype (stratified pool design).
In the latter case, we assume that the quantitative trait phenotype has been measured
on all individuals, and mRNA expression levels are only measured in the pools rather
than individuals.
We investigate whether the two pooling strategies differ in terms of the bias and
precision with which we can estimate the correlation between gene expression and phe-
notype. To do so, we use simulated data, where the true correlation coefficient is known.
We first simulate phenotype and expression levels as bivariate normally distributed vari-
ables. Then we assume that a pool’s mRNA expression level is the average of mRNA
expression levels of all the individuals in the same pool. We calculate the widely used
Pearson correlation coefficient for both pool designs. We find that in the stratified pool-
ing design, the Pearson correlation overestimates the true correlation between phenotype
and gene expression levels. Therefore, we propose an algorithm to obtain a maximum
likelihood (ML) estimator of the correlation between phenotype and mRNA expression
levels in both pool designs. We also derive a likelihood ratio test to identify the genes
whose expression levels are correlated with phenotype. By simulation studies, we find
that tge maximum likelihood approach not only provides less biased and more precise
estimation in stratified pool design than that in random pool design, but also has higher
power to determine trait-related pathway genes. Therefore, the stratified pool design is
a preferable choice in terms of bias, precision and power. This manuscript is organized
as follows. In Section 3.2, we introduce the two pooling stratifies and describe the ap-
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proach for obtaining Pearson product moment and ML correlation estimates. Section 3.3
includes details about the simulation study and the results that were obtained. Finally,
a discussion and some conclusions are presented in Section 3.4.
3.2 Methods
3.2.1 Notation and models for random and stratified pool designs
For simplicity of notation, a single gene is considered in the following derivation and
analysis. We use yi to denote the phenotypic measurement and xi to denote the log
scale gene expression level of a single gene for the ith individual. We assume that (yi, xi)
are jointly normally distributed with mean (µy, µx), variance (σ
2
y , σ
2
x) and correlation ρ
(Wang and Nettleton, 2006), i.e.,
 yi
xi
 = N

 µy
µx
 ,
 σ2y ρσyσx
ρσyσx σ
2
x

 , (3.1)
where i = 1, ..., N . Here N is the total number of individuals in the microarray experi-
ment.
In microarray experiments, we cannot directly measure the true mRNA expression.
Instead, we measure the observed mRNA expression level, which contains technical error.
Technical error can potentially be introduced at each step of a microarray experiment,
including sample preparation, array construction, hybridization and washing procedures
and signal detection process (Chen et al., 2004 and Churchill, 2002). Therefore, we
extend the model to account for technical error. We propose that the observed mRNA
expression level be written as the sum of true mRNA expression level and technical error
(²i), i.e.,
oi = xi + ²i, (3.2)
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where ²i is independently, identically distributed as N(0, σ
2
t ) and independent of xi and
yi. Here, σ
2
t is the technical variance introduced in microarray process. Then, based
expressions (3.1) and (3.2), yi and oi are still jointly distributed as yi
oi
 = N

 µy
µx
 ,
 σ2y ρσyσx
ρσyσx σ
2
x + σ
2
t

 . (3.3)
Therefore, the correlation between yi and oi is can be derived as follows,
Cor(yi, oi) =
ρσyσx√
σ2y(σ
2
x + σ
2
t )
= ρ
√√√√ σ2x
σ2x + σ
2
t
. (3.4)
In the designs with mRNA pooling, a pool’s mRNA expression level is assumed to
be the average of mRNA expression levels of all the individuals in the pool. Similarly,
a pool’s phenotypic value is defined as the average of phenotypic values of all the indi-
viduals in the same pool. Let xpi and y
p
i be the mRNA expression level and phenotypic
value for the ith pool. Then
ypi =
∑n
j=1 yij
n
, (3.5)
xpi =
∑n
j=1 xij
n
, (3.6)
where i = 1, 2, ..., P and j = 1, 2, ..., n. Here, xij and yij are mRNA expression level and
phenotypic value of the jth individual for the ith pool, P is the number of pools, and n
is the number of individuals per pool, so that P ∗n = N . Again, we model the observed
mRNA expression level for a pool as the sum of the true mRNA expression level for a
pool and technical error. Then,
opi = x
p
i + ²i. (3.7)
In a random pool design, each individual is randomly assigned to a pool. Therefore,
based on expressions (3.1), (3.5), (3.6) and (3.7), the observed mRNA expression level
and phenotypic value for a pool is still bivariate normal distributed, i.e.,
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 y
p
i
opi
 = N

 µy
µx
 ,
 σ2y/n ρσyσx/n
ρσyσx/n σ
2
x/n+ σ
2
t

 . (3.8)
Therefore, the correlation between observed mRNA expression level and phenotypic
value for a pool is
Cor(ypi , o
p
i ) =
ρσyσx/n√
(σ2y/n)(σ
2
x/n+ σ
2
t )
= ρ
√√√√ σ2x
σ2x + nσ
2
t
. (3.9)
Notice that the presence of technical error has the effects of attenuating the correla-
tion between ypi and o
p
i .
With a stratified pool design, the N individuals are pooled as follows: (1) First, order
the N individuals according to the value of yi, where the ordered yi is denoted by y(i).
Here, y(i) stands for the i
th smallest phenotypic value. The xi corresponding to y(i) is
denoted as x[i]. We say that x[i] is a concomitant to y(i). (2) Construct P pools of size
n by pooling the n samples with the smallest phenotype values, the n samples with the
next smallest phenotype values, etc. Then, the average phenotype (ypi ) and the true and
observed mRNA expression levels (xpi and o
p
i ) for the i
th stratified pool are:
xpi =
∑i×n
j=1+n(i−1) x[j]
n
, (3.10)
ypi =
∑i×n
j=1+n(i−1) y(j)
n
, (3.11)
and
opi =
∑i×n
j=1+n(i−1) o[j]
n
, (3.12)
Where o[j] is x[j] plus measurement error.
Since the pools in the stratified pool design are not created by randomly selecting n
individuals from the experimental group of N , the joint distribution of (opi , y
p
i ) no longer
follows expression (3.8). We now discuss two approaches to estimating the correlation
between the true gene expression and phenotypic values.
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3.2.2 Pearson product-moment correlation method
The Pearson product-moment correlation method is widely used to detect whether
gene expression is correlated with the phenotype for the trait of interest in the experi-
ments in which one microarray is obtained for each individual (Anbahagan et al., 1999,
Agrawal et al., 2002, Scherf et al., 2000 and Ueda et al., 2002). Let r denote the Pearson
product-moment correlation coefficient estimate between x and y. Then,
r =
N
∑N
i=1 xiyi −
∑N
i=1 xi
∑N
i=1 yi√
N
∑N
i=1 x
2
i − (
∑N
i=1 xi)
2
√
N
∑N
i=1 y
2
i − (
∑N
i=1 yi)
2
. (3.13)
When the mRNA of n individuals has been pooled, the Pearson product-moment
correlation coefficient between phenotype and gene expression can be, in principle, cal-
culated by replacing xi and yi with x
p
i and o
p
i . If we assume σ
2
x and σ
2
t are known, given
the Pearson product-moment correlation estimator and the relationship between corre-
lation coefficient based on individual and pool data (expression 3.9), we can estimate
the true correlation of gene expression and phenotypic value (ρ) for the unobservable
individual measurements by
rˆ = sign(r)min
∣∣∣∣∣∣r
√√√√σ2x + nσ2t
σ2x
∣∣∣∣∣∣ , 1
 . (3.14)
To investigate whether r is a good estimator of ρ when mRNA has been pooled, we
simulated gene expression and phenotypic values as follows. We initially generated 500
pairs (xi, yi) (N=500) from model (3.1) with variances for mRNA expression level and
phenotype fixed at 1 (σ2x = 1, σ
2
y = 1) and with σ
2
t = 0. We varied the true correlation
between gene expression and phenotype between -1 and 1 (ρ = −1.0,−0.9, ..., 1.0). We
then constructed pools of size 5 (n = 5) or pools of size 10 (n = 10) either randomly
or stratifying by phenotypic value. A pool’s mRNA expression level and phenotypic
value are calculated as in expression (3.5) and (3.7) or expression (3.11) and (3.12).
Finally, we calculated the Pearson correlation coefficients to estimate the correlation
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between phenotypic value and mRNA expression in the two types of pools. The results
are shown in Figure 3.1. Figure 3.1 clearly show that the Pearson product-moment
correlation method gives an almost unbiased estimation of ρ in random pool design, but
it overestimates the true correlation between mRNA expression levels and phenotype
when the pools are constructed by grouping individuals according to phenotype. These
results indicate that the Pearson product-moment correlation estimate can be severely
biased when pools are stratified by phenotype. We show, in next section, however that a
maximum likelihood approach results in an almost unbiased estimation of the correlation
in stratified pools with similar or or even higher precision.
3.2.3 Maximum likelihood estimation
We have shown that the standard Pearson correlation estimate is biased when indi-
viduals are stratified by phenotype. Here, we propose a ML approach to estimate the
correlation between gene expression and phenotype. Because a closed form maximizer
of the likelihood is unavailable, we obtain the MLE of ρ (ρˆ) numerically.
We now describe the two steps in the derivation of likelihood function (L) i.e.,
L(µx, µy, σ
2
x, σ
2
y , σ
2
t , ρ|Op, Y ) = f(Op, Y |µx, µy, σ2x, σ2y , σ2t , ρ) (3.15)
= f(Op|Y, µx, µy, σ2y , σ2t , ρ)f(Y |σ2y , µy). (3.16)
where Y = (y1, y2, ..., yN)
t, Op = (op1, o
p
2, ..., o
p
P )
t, fs are the density functions for Op|Y
and Y .
First, based on model (3.1), it is straight forward to write the marginal distribution
of Y , i.e.,
f(Y ) =
exp[−1
2
(Y − µy)tΣy−1(Y − µy)]√
(2pi)N |Σy|
. (3.17)
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Figure 3.1 Pearson product-moment correlation coefficient estimates
in the random pool design and the stratified design
(N = 500, n = 5, P = 100, σ2x = 1, σ
2
y = 1, and
ρ = −1.0,−0.9, ..., 1.0).
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Here, Σy is the variance-covariance matrix of Y , and equal to σ
2
yIN×N , where IN×N is a
N ×N identity matrix.
The next step is to derive the distribution of Op conditional on Y . Recall that for the
ith individual, (yi, xi) is assumed to be bivariate normally distributed. Then, conditional
on phenotype, gene expression is also normally distributed and can be written as
xi|yi = µx + ρσx
σy
(yi − µy) + ²i, (3.18)
where ²i is independent, identically distributed as N(0, σ
2
x(1− ρ2)).
Let X = (x1, x2, ..., xN)
t, ² = (²1, ²2, ..., ²N)
t, and µX|Y = µx + ρσxσy (Y − µy). We can
rewrite expression (3.17) in matrix form, i.e.,
X|Y = µX|Y + ², (3.19)
where Var(²) = σ2x(1− ρ2)IN×N.
Let Mp×N denote the design matrix in a pooled mRNA design which assigns each
(xi, yi) to one of the P pools. Then, conditional on phenotypic values, the average
mRNA expression level in the pools is still normally distributed and can be written as
Xp|Y = M ×X|Y = M × µX|Y +M × ², (3.20)
where Xp = (xp1, x
p
2, ..., x
p
P )
t. In our design with P pools of size n, the MP×N matrix
has a specific format: each row of MP×N contains P entries equal to 1/n and N − P
entries equal to 0. Therefore, expression (3.19) can be simplified to
Xp|Y = µXp|Y p + ²p, (3.21)
where µXp|Y p = µx + ρσxσy (Y
p − µy), Y p = (yp1, yp2, ..., ypP )t and ²p = (²p1, ²p2, ..., ²pP )t.
Here, ²pi is independent, identically distributed as N(0, σ
2
x(1 − ρ2)/n) and Var(²p) =
Σxp = σ
2
x(1− ρ2)/nIP×P. Based on the expression (3.7) and (3.20), we can easily derive
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that
Op|Y = µXp|Y p + ε, (3.22)
Where ε is multivariate normally distributed with mean equal to zero and variance (ΣOp)
equal to (σ2t + σ
2
x(1− ρ2)/n)IP×P .
Then, the likelihood function can be written as
L =
exp[−1
2
(Op − µxp|yp)tΣop−1(Op − µxp|yp)− 12(Y − µy)tΣy−1(Y − µy)]√
(2pi)P |Σop |(2pi)N |Σy|
,(3.23)
or equivalently, its log
logL ∝ −P
2
log(
σ2x(1− ρ2)
n
+ σ2t )−
n
∑P
i=1(o
p
i − µx − ρσxσy (y
p
i − µy))2
2(σ2x(1− ρ2) + nσ2t )
−N
2
log(σ2y)−
∑N
i=1(yi − µy)2
2σ2y
. (3.24)
Note that phenotypic values of all individuals and mRNA expression levels of pools
are known, so we can calculate MLE for µx, µy and σ
2
y as
µˆx =
∑N
i=1 oi
N
=
∑P
i=1 o
p
i
P
= opi , (3.25)
µˆy =
∑N
i=1 yi
N
=
∑P
i=1 y
p
i
P
= ypi , (3.26)
σˆ2y =
N∑
i=1
y2i − (
N∑
i=1
yi)
2/N. (3.27)
We also assume technical variance can be well estimated from literature or by mea-
suring samples repeatedly to obtain σˆ2x. It is straight forward to show that
L(µx, µy, σ
2
y , σ
2
x, σ
2
t , ρ|Op, Y ) ≤ L(µˆx, µˆy, σˆ2y , σˆ2t , σ2x, ρ|Op, Y )
for any values in the parameter spaces. Therefore, maximization of the likelihood func-
tion (L) with respect to µx, µy, σ
2
x, σ
2
y , σ
2
t and ρ can be accomplished by numerically
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maximizing L(µˆx, µˆy, σˆ
2
y , σˆ
2
t , σ
2
x, ρ|Op, Y ) with respect to σ2x and ρ. According to the al-
gorithm proposed by Nelder and Mead (1965), we numerically solved the MLE for σ2x
and ρ by the optim function in R.
3.2.4 A test of the hypothesis: ρ = 0
In addition to the estimation of the correlation between phenotype and gene ex-
pression, another important objective in microarray experiments is to identify the genes
whose expression level are significantly related to the phenotype of interest. Therefore,
we propose three different approaches to test if ρ = 0: the likelihood ratio test based
on the MLE, a test based on Fisher’s z-transformation for Pearson product-moment
correlation estimates, and a permutation test.
We first apply the likelihood ratio test of H0 : ρ = 0. The test statistic is given by
−2 log λ, where
λ =
L(0, σˆ2x, σˆ
2
y , σˆ
2
t , µˆx, µˆy|Op, Y )
L(ρˆ, σˆ2x, σˆ
2
y , σˆ
2
t , µˆx, µˆy)|Op, Y )
.
(3.28)
From expression (3.25), we find that
−2 log(λ) = P log( σˆ
2
x(1− ρˆ2)
n
+ σˆ2t ) +
n
σˆ2x(1− ρˆ2) + nσˆ2t
P∑
i=1
(opi − µˆx − ρˆ
σˆx
σˆy
(ypi − µˆy))2
−P log( σˆ
2
x
n
+ σˆ2t )−
n
σˆ2x + nσˆ
2
t
P∑
i=1
(opi − µˆx − ρˆ
σˆx
σˆy
(ypi − µˆy))2. (3.29)
The test rejects the null hypothesis that ρ = 0 at level α if −2 log(λ) ≥ χ2df,α. Here,
df is the degrees of freedom for the test and is equal to 1 in our application.
An alternative testing approach is to use Fisher’s z-transformation of Pearson product-
moment correlation estimates to test whether ρ = 0 (Dunn and Clark, 1969), i.e.,
Zr =
1
2
log
(
1 + r
1− r
)
. (3.30)
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Here, r is the Pearson product moment correlation estimate. When ρ = 0, Zr is approx-
imately normally distributed as N(0, 1
P−3) in the random pool design, where P is the
number of pools as defined before.
Besides the two parametric hypothesis tests, we can also consider a nonparametric
permutation test to identify the genes which are truly related to phenotype. In this
test, we break the pairing relationship between the mean phenotype of a pool and the
gene expression of the same pool by randomly shuﬄing the gene expression of pools
while keeping the mean phenotypes unchanged. Then, we calculate Pearson correlation
estimate for each permutation and form the sampling distribution of the estimates.
Based on the sampling distribution of Pearson correlation estimates, we calculate the p
value of the Pearson product-moment correlation for the un-permutated data as
p =
1
M
M∑
k=1
1(|r| ≤ |rk|), (3.31)
where rk is the correlation for the k
th of M permutations. Rather than computing rk for
all P ! permutation, we obtain a monte carlo approximation to the permutation p value
by considering M=1000 randomly selected permutations.
3.3 Results
3.3.1 Pearson product-moment and ML approaches to estimating ρ in the
absence of technical error.
We simulated true mRNA expression levels and phenotypes (xi and yi) for 100 in-
dividuals (N = 100) according to expression (3.1) with σ2x = 4, σ
2
y = 1, σ
2
t = 0 and
ρ = 0.1, 0.2, ..., 0.9. Pools were created by either randomly allocating individuals to
pools or by first stratifying individuals by phenotypic value. In all cases, pools consisted
of 10 individuals (n = 2 and P = 50). The expression levels and phenotypic values were
calculated as the average of all individuals in the same pool.
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We calculated the standard Pearson correlation coefficient and the proposed ML esti-
mate of the correlation coefficient using data simulated under three different conditions:
when mRNA samples were analyzed individually (individual design), when mRNA pools
were constructed at random (random pool design) and when individuals were first strat-
ified on the basis of phenotypic value and the mRNA of “similar” individuals was then
pooled (stratified pool design).
When microarrays were performed on each individual sample, both approaches for
estimating the correlation between phenotype and gene expression resulted in nearly
unbiased estimates with similar precision (Table 3.1). Similarly, when pools were con-
structed by randomly grouping individuals, the two approaches also resulted in nearly
unbiased estimates with similar precision. However, the precision of correlation esti-
mates was substantially less for the random pool design than the individual design, as
we expected. This is because we have fewer observations to estimate the correlation
when mRNA samples are pooled.
For the stratified design, the standard Pearson correlation coefficient estimate was
biased and tended to over-estimate the absolute magnitude of the true correlation. The
MLE on the other hand, even though slightly biased, appeared to estimate the true
correlation much more closely. The standard deviation of the MLE was much lower for
the stratified pool design than for the random pool design, but still higher than for the
individual design.
Results in Table 3.1 were for relatively large numbers of individuals and larger num-
bers of individuals in each pool (N and n). We now investigate the behavior of the
Pearson correlation estimates and the MLE further in small samples (Table 3.2). By
comparing Tables 3.1 and 3.2, the behavior of the two correlation estimates is similar
regardless of the sample size (N). However, when N and P are relatively small, the
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two correlation estimators tended to be a little more biased and the precision also de-
creased as N and P decreased. As expected, the Pearson correlation estimator and ML
estimator perform better when samples are large.
3.3.2 Pearson product-moment ML approaches to estimating ρ in the pres-
ence of technical error.
Consider now the more realistic scenario where technical error is not negligible. We
again evaluated the performance (in terms of bias and precision) of the two approaches
for estimating the correlation between phenotype and gene expression using individual
mRNA samples and under the two pooling strategies. We simulated phenotypic and
gene expression values as described in Section 3.3.1, but now added a technical error
distributed as an iid normal random variable with mean 0 and variance σ2t = 1.
In order to estimate the association between phenotype and gene expression using the
Pearson product-moment approach, we proceeded in two steps. We first estimated the
correlation coefficient using the observed gene expression and the observed phenotypic
value in the pools (opi and y
p
i ). We then used expression (3.9) to obtain an estimate of
ρ, the correlation between phenotype and true gene expression at the individual level
by assuming the σ2x and σ
2
t are known. Results are presented in Table 3.3. Results for
the individual design were similar to those obtained when technical error was not taken
into account in the model. Both estimators were essentially unbiased and had similar
standard deviation. For the random pool design, both approaches also tended to give
an unbiased estimate with similar precision. For the stratified pool design, however,
the MLE appeared to outperform the standard Pearson correlation coefficient. The
empirical bias of the MLE was much smaller than that of the Pearson estimate for all
values of the true correlation. Surprisingly, the standard deviation was not uniformly
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smaller for the MLE. Because the bias of the standard Pearson estimate was so much
larger than that associated to the MLE, however, the mean squared error of the MLE
is below that of the Pearson estimate for all values of ρ. Notice also that when ρ is high
(0.9 and above), Pearson product-moment estimate can be outside of the parameter
space. This can occur because the estimator of ρ obtained from expression (3.9) is not
bounded and therefore must use expression (3.14) as the estimator of ρ. The MLE, by
construction, will always be inside the parameter space. When comparing Table 3.1
and 3.3, the standard deviation for the designs without technical error was always lower
than that for the designs with technical error, regardless which of the three designs was
applied.
In the presence of technical error, the behavior of the two estimates was again evalu-
ated for the small sample size scenario (Table 3.4). The behavior of the two estimators
in the presence of technical error is the same as it is in the absence of technical error. We
again observe that in the individual design and in the random design, both approaches
results in a slightly biased estimates with similar precision. When pools are stratified
by phenotype, the ML approach is superior to the Pearson product-moment correlation
approach in terms of bias and standard deviation.
3.3.3 A test of the hypothesis: ρ = 0
A test of the hypothesis that the correlation between phenotype and expression level
is zero can be carried out using a likelihood ratio test, Fisher’s z-transformation or
a permutation test as described in Section 3.2.4. In this section, we first investigate
whether the test statistic for the likelihood ratio test proposed in expression (3.30) has
the anticipated asymptotic distribution. To do so, we use the simulated data described
in Section 3.3.1, for the case where the true correlation between phenotype and gene
expression is equal to 0. In each of the 1000 replicate data sets, we first obtain ρˆ, the
MLE of ρ, and then carry out a test of hypothesis:
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H0 : ρ = 0 Ha : ρ 6= 0
using a likelihood ratio testing approach.
The type I errors at different significant levels under H0 : ρ = 0 (over the 10000 repli-
cates) for the three designs are shown in Table 3.5. The distribution of the test statistics
are almost uniformly distributed, which suggested that the test statistic proposed in Sec-
tion 3.2.4 can in fact be used to draw inference about the true linear association between
phenotype and gene expression. Besides the likelihood ratio test, we also studied the
behavior of the test based on Fisher’s z-transformation (Table 3.5). The results also
justified the validity of this test in three different designs.
Furthermore, we compared the performance of the permutation test, the likelihood
ratio test, and Fisher’s z-transformation test on the basis of power across the three
scenarios: individual, randomly or stratified pooled samples (Table 3.6). We found that
the permutation test, likelihood ratio test and Fisher’s z-transformation test had almost
the same power in all three different designs. The power based on individual samples is
highest as would be expected given that information is lost in the process of pooling. It
is interesting to notice, however, that the loss of power was less when pools are stratified.
Therefore, a design that involves stratifying individuals by phenotype before pooling may
sometimes be preferred because we might be able to reduce the cost of experimentation
without compromising power.
3.4 Discussion
Microarray studies using mRNA samples pooled across individuals are often con-
ducted when there is not enough individual mRNA sample to hybridize or when costs
prevent obtaining a separate array for each individual. In such designs, gene expression
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Table 3.6 The power comparison between the likelihood ratio test, permuta-
tion test and Fisher’s z-transformation in individual, random and
stratified pool designs (N = 100, n = 2, P = 50, σ2x = 4, σ
2
y = 1,
and σ2t = 0). The results are shown as the percentage of signifi-
cance at 0.05 level from 1000 replicates.
ρ 0 0.1 0.2 0.3 0.4 0.5
Individual Likelihood ratio test 0.05 0.17 0.50 0.86 0.99 1.00
design Permutation test 0.05 0.17 0.51 0.85 0.98 1.00
Fisher’s z-transformation 0.06 0.17 0.50 0.85 0.99 1.00
Random Likelihood ratio test 0.05 0.09 0.28 0.55 0.80 0.96
pool Permutation test 0.05 0.11 0.29 0.54 0.79 0.96
design Fisher’s z-transformation 0.05 0.10 0.29 0.55 0.80 0.95
Stratified Likelihood ratio test 0.06 0.15 0.48 0.83 0.97 1.00
pool Permutation test 0.05 0.14 0.48 0.83 0.97 1.00
design Fisher’s z-transformation 0.06 0.17 0.49 0.85 0.98 1.00
is measured on the pools rather than on each individual. While pooling mRNA samples
can significantly decrease the cost of the experiment, it can also create some challenges.
For example, estimation of the correlation between phenotype and gene expression using
the standard approach can lead to severely biased estimates depending on the value of
the true underlying correlation, the strategy for constructing pools, and the relative size
of the technical error variance.
We show that the widely used Pearson product-moment method for estimating the
correlation works well in terms of bias and precision when mRNA pools are created
randomly but not when individuals are stratified by phenotype prior to pooling. In the
latter case, the Pearson correlation coefficient overestimates the magnitude of the true
correlation. As Figures 3.1 suggests, the bias tends to increase as pool size (n) increases.
One explanation for the bias of the Pearson correlation in stratified pool designs is that
it ignores the specific structure of the pool. In the stratified pools, the ordered mean
phenotypic values of pools and their concomitant gene expression levels can no longer
be considered to be independent, and identically distributed.
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In this manuscript, we propose a maximum likelihood approach to estimating the
correlation between phenotype and gene expression in experiments that include mRNA
pooling. Via simulation studies, we find this method is effective in terms of bias and
precision for both random and stratified pool designs. When pools are made up of ran-
domly selected individuals, both the Pearson and the ML approaches exhibit similar
behaviors in terms of bias and precision. When individuals are stratified on the basis
of phenotype, the MLE is superior to the Pearson product-moment estimate in terms
of bias. Further, the standard deviation of the MLE in stratified pools is lower than
the standard deviation of the MLE in random pools. Therefore, if a pooling strategy is
needed due to cost constraints or limited amounts of mRNA, a design in which individ-
uals with similar phenotypic values are pooled can be a good choice. In that case, the
MLE of the correlation results in estimates which are almost unbiased and have lower
variance than estimates obtained from randomly constructed pools.
Clearly, we can think of a design in which no mRNA samples are pooled as the ”gold
standard”. We therefore compared the performance of the two estimation approaches
using pooled samples to their performance when using individual samples. The stan-
dard deviation of the MLE based on individual samples is lower regardless of pooling
strategy. This is to be expected given that some information is lost when pooling indi-
vidual samples. In the case of the Pearson product-moment correlation approach, the
standard deviation of estimates in the stratified pool design is sometimes lower than in
the individual design and in the random pooling design when |ρ| is large. The surprising
finding can be explained by noticing that the estimates are biased upward but at the
same time are bounded within (−1, 1).
Besides the estimation of the correlation between phenotype and gene expression
level, we also propose three different tests to identify the genes whose expression level are
truly correlated with phenotype. We find that the likelihood ratio test, the permutation
test and Fisher’s z-transformation test are appropriate for all three designs. While
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the power for detecting a non-zero correlation is always higher when the test is based
on individual samples, the loss due to pooling samples is smaller when individuals are
stratified by phenotype. Therefore, when pooling mRNA is required in the experiment
designs, the stratified pools are again preferred in terms of the power to identify the
trait related genes. In both the likelihood ratio approach and Fisher’s z-transformation
test, the technical variance was assumed to be well known, which is not required in
the permutation test. Therefore, if the main objective is to pick up the trait related
genes, not to estimate the correlation between genes and phenotype, the permutation
test is more desirable than likelihood ratio test, since it does not require an estimate on
technical variance.
Technical error can be introduced in the multiple steps of a microarray experiment.
When technical error is relatively large (as compared to biological variability), it should
be taken into account in the statistical models. In this work, we assumed the technical
variance is known. Otherwise, we would not be able to separate biological variance
from technical variance because we assume each sample is only measured once. In
practice, researchers can use an estimate of technical variance from the literature or
obtain replicate measures on the same samples. If technical error is negligible, but can
not be well estimated, we can still use ML or Pearson correlation approaches in absence
of technical error as in Section 3.3.1. By this means, the estimation of correlation
will conservative, and the magnitude of true correlation will tend to be larger than
estimated. Notice that the power to test if a gene is truly correlated with phenotype is
also conservative, and the true power is at least as high as the predicted.
One assumption about mRNA pooling is that the mRNA expression level for a pool is
the average of mRNA expression levels of all individuals in the pool. For each individual,
we have assumed that the log scale mRNA expression level and phenotypic value can be
assumed as bivariate normal distribution. Therefore, based on the pooling assumption,
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a pool’s mRNA expression level on the log scale should be first calculated as the log
of the average of mRNA expression levels on the original scale of all individual in the
same pool. However, the distribution of a pool’s mRNA level on the log scale derived
by this assumption is no longer normally distributed and is analytically intractable.
Simulations and goodness-of-fit testing show that it can be well approximated by a
normal distribution (Zhang et al. 2006). Therefore, our assumption that the mRNA
expression level and phenotypic value for a pool are joint normally distributed is a
reasonable choice.
Overall, the proposed ML approach is superior to the Pearson correlation method
in designs involving mRNA pooling because it out forms the Pearson product-moment
correlation method in the stratified pool design and at least as effective in the individual
and the random pool design. Further, the ML method can be used to construct a
likelihood ratio test to determine whether gene expression levels is related to phenotype.
These genes play an important role in studying genetic regulation and pathways of
phenotype trait. Because the ML method is relatively complex and computationally
intensive, the standard Pearson correlation method may be preferred when pools are
created randomly. When pools are created according to phenotypic value, the Pearson
correlation method is no longer valid, and the ML approach results in estimates of ρ
with less bias and low standard deviation. The ML approach can be used not only in
the three designs, but also in more complex designs of QTL scenario. In such a design,
pools can be created by QTL genotypes, and stratified within each QTL genotype. ML
approaches can still estimate the true correlation between genotype and gene expression
within each genotype and pick up the genes which are truly correlated with phenotype
trait of interest.
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CHAPTER 4. pQTL TRANSCRIPTOME MAPPING: A
METHOD TO INTEGRATE QTL MAPPING AND GENE
EXPRESSION ANALYSIS TO DISCOVER THE GENETIC
BASIS OF COMPLEX TRAITS
Wuyan Zhang, Alicia Carriquiry, Dan Nettleton, and Jack C.M. Dekkers
Abstract: eQTL transcriptome mapping blends the power of quantitative trait locus
(QTL) mapping with gene expression analysis and enables genome-wide identification
of positional candidate genes for QTL and of genes involved in metabolic pathways for
the phenotypic trait. Current methods for eQTL transcriptome mapping require con-
ducting individual microarray assays on a large number of individuals to reach adequate
statistical power. This is prohibitively expensive for most labs. Therefore an alternative
mapping approach (pQTL transcriptome mapping) is proposed, which can dramatically
decrease the cost of the experiment while still maintaining sufficient statistical power.
This approach essentially consists in implementing eQTL transcriptome mapping using
gene expression measures in pooled mRNA samples obtained from a group of individ-
uals. By pooling mRNA samples, it is possible to reduce the cost of experimentation
and target the generation of expression data that are relevant to the phenotypic traits of
interest. To test the validity of the pQTL transcriptome mapping concept, comprehen-
sive data on an F2 cross population were first simulated at the genome, transcriptome,
and phenome levels. Then, we assumed that gene expression levels in mRNA pools are
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a weighted average of the gene expression of all individuals in the pool. These averages
are taken on the original measurement scale and the weights correspond to individual
sample contributions to the pool. Based on simulated data for the mRNA pools, we
empirically calculated the power of pQTL transcriptome mapping approaches for find-
ing candidate genes and trait pathway genes using regression and composite mapping
methods. We found that pQTL transcriptome mapping using the standard regression
method achieved statistical power comparable to the power that can be achieved by
eQTL transcriptome mapping. However, when pQTL transcriptome mapping is carried
out via composite interval mapping which takes into account linkage disequilibrium ef-
fects, there was significant loss of power.
KEY WORDS: mRNA pooling; transcriptome mapping; power.
4.1 Introduction
Many common human diseases or traits of economic importance in livestock are af-
fected by multiple genes. The identification of these genes and the understanding of
the underlying pathway are very important. Standard quantitative trait locus (QTL)
mapping gives the first insight into the genetic architecture of an organism (Andersson,
2001). In this approach, a resource population that segregates for the traits of interest
(e.g. F2) is created, and associations between trait phenotypes and genetic markers
across the genome are used to identify chromosomal regions that harbor loci that con-
tribute to genetic variation in phenotypic traits (phenome QTL, pQTL). However, the
pQTL region identified in this approach can be large (20-40cM), and further, the genes
and their underlying pathway remain unknown. Recently, eQTL transcriptome mapping
has been proposed, which integrates the power of quantitative trait locus (QTL) map-
ping with gene expression analysis and allows us to investigate the genetic regulatory
pathways at the mRNA level (Jansen and Nap, 2001).
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Microarray technology is a rapidly developing technology, with applications in many
species (Gibson and Weir, 2005). This technique permits measuring the expression level
of tens of thousands of genes simultaneously under different experimental conditions or
over different time periods. Therefore, a microarray experiment can be used to detect
genes (DE genes) which are differentially expressed under different conditions. Jansen
and Nap (2001) first proposed integrating global gene expression analysis with QTL
mapping in a multi-factorial manner, to allow the analysis of multiple QTL. In this
approach, here called eQTL transcriptome mapping, individuals in a QTL mapping
population (e.g. an F2 cross) are individually evaluated for global gene expression and
genotyped for markers across the genome. Then, standard QTL mapping methods are
used to identify QTL (expression QTL, eQTL) that control variation in the level of
expression of individual genes by considering expression of a given gene as a quantita-
tive phenotype. This analysis identifies genome regions that harbor genes (eQTL) that
control transcription levels of a gene or genes. eQTL transcriptome mapping bridges
the gap between genome sequence variation and phenotypic variation by the analysis of
transcriptome RNA variation (Figure 4.1).
We now discuss further the relationship between pQTL, eQTL and differentially
expressed genes. QTL (pQTL or eQTL) are genes/genome regions that harbor one or
more sequence polymorphism that affect the trait phenotypic value or gene expression
level. eQTL control variation in mRNA expression level while pQTL control variation in
a phenotypic trait. Differentially expressed genes are genes whose level of transcription
varies in the population. They are not necessarily polymorphic. In addition, not all
QTL will themselves be identified as differentially expressed genes but all will result
in a structural transcript difference rather than in differences in transcript abundance
(Figure 4.1).
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Figure 4.1 Relationships between and methods for analysis of genome, tran-
scriptome, and phenome variation
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The eQTL transcriptome mapping approach has been applied to several species (Bao
et al., 2006; Brem et al., 2003; Bystrykh et al., 2005; Chesler et al., 2005; Decook et
al., 2006; de Koning et al., 2005; Hubner et al., 2005, Kirst et al., 2004; Pomp et
al., 2004; Schadt et al., 2003). The relationship between differentially expressed genes
and their associated eQTL are summarized into two categories: cis-acting (an eQTL
that affects the expression of itself), and/or trans-acting (an eQTL that affects the
expression of other distant genes). Yvert et al. (2004) performed eQTL mapping in
yeast and found 2294 genes whose expression phenotype was associated with eQTL.
Only 25% of 2294 genes were co-localized with the corresponding structural gene (cis-
acting) and 75% were transacting. Brem et al. (2002) identified 570 genes in yeast which
were associated with one or more eQTL. Sixty four percent of differentially expressed
genes were trans-acting and controlled by a small group of eQTL each regulating 7 to 94
genes of related function. In fact, it has been postulated (Pomp, 1999) and supported
by evidence (Gibson and Weir 2005; Hubner et al., 2005; Pomp et al., 2004), that about
two third of trait-associated gene expression differences are trans-acting and not caused
by a polymorphism in the gene itself but by polymorphism at eQTL in other parts of
the genome. Although cis-acting association is not as prevalent as trans-acting, the
effects of cis-acting eQTL tend to be much stronger (Doss et al., 2005; Schadt et al.,
2003). Differentially expressed genes that are associated with cis-acting eQTL have been
reported as important candidate genes for diseases or phenotypic trait (Hubner et al.
2005; Pamler et al., 2005; Yaguchi et al., 2005). Therefore eQTL transcriptome mapping
helps to identify candidate genes underlying QTL on a global basis and gives us a deeper
insight into regulatory pathways and genetic architecture.
In contrast with the rapid development of eQTL mapping methods, little has been
written about the power with which we can identify eQTL affecting certain gene ex-
pression. No formal approach for calculating power in eQTL studies has been proposed,
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perhaps because estimating statistical power in eQTL studies is not straight forward
(Kendziorski and Wang, 2006). Difficulties arise because power calculations must ac-
count for the power associated with mapping and with gene expression analyses. Re-
cently, de Koning and Haley (2005) proposed methodology to calculate power in various
eQTL experimental designs but ignored the challenges that arise because of the in-
evitable multiple testing in microarray experiments. They found that the power of most
eQTL studies to detect loci involved in gene regulation is limited. As a result, they ar-
gued that most studies can be expected to fail to detect many loci with moderate effects
and even some loci with major effects. What contributes to the typically low power in
eQTL studies? Besides small sample sizes, linkage disequilibrium also complicates the
identification of a true regulatory eQTL. Pastinen and Hudson (2004) confirmed that
one SNP was falsely considered to be involved in gene regulation because of its high
linkage disequilibrium with the causative regulatory eQTL.
eQTL transcriptome mapping is relatively expensive due to the large number of mi-
croarray experiments that must be performed on each individual if we wish to achieve
sufficient statistical power. Also, eQTL transcriptome mapping finds not only the dif-
ferentially expressed genes and the eQTL related to the trait of interest but also those
not related to the trait phenotype. Further analysis is needed to pick out those genes
and QTL of interest (Schadt et al., 2003, Drake et al., 2006). Therefore, we discuss
an alternative approach denoted pQTL transcriptome mapping (Cabrera et al., 2006)
which has the potential to locate trait-related genes at a fraction of the cost of the usual
eQTL methodology. We describe the approach in the next section, and later in this
manuscript use simulation studies to assess its performance. We argue that the pQTL
transcriptome mapping approach can identify genes and pathways that contribute to
variation in the phenotypic trait. Even though there is a loss of statistical power, the
cost of a pQTL experiment can be dramatically lower than the cost of the corresponding
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eQTL study, and this may make the pQTL approach feasible in most laboratories.
4.2 Methods
4.2.1 The concept of pQTL transcriptome mapping
The main objective of the pQTL transcriptome mapping approach is to identify
genes whose expression is controlled by a pQTL, by identifying genes that are differ-
entially expressed between individuals with different pQTL genotypes. This approach
first pinpoints the pQTL of interest, then finds genes that are differentially expressed
in individuals with alternate genotypes at the pQTL. One potential advantage of the
proposed pQTL transcriptome mapping approach is that it might not require individual
microarray experiments. Instead, we might be able to pool mRNA from individuals with
the same pQTL genotype and then do the microarray on the pooled mRNA samples.
Thus, the pQTL transcriptome mapping approach can result in substantial savings in
experimental costs, a dramatic reduction in the amount of data that must be processed
while also help uncover direct associations of QTL with the trait of interest.
The steps that must be followed in a pQTL transcriptome mapping experiment
include the following:
1. Using standard procedures, set up a QTL resource population (e.g. F2 cross),
evaluate individuals in the population for trait phenotypes and genotype the individuals
for genome-wide markers. Collect RNA from tissues of interest.
2. Conduct a standard pQTL scan for the phenotypic traits of interest.
3. For a given pQTL region, group individuals by pQTL genotype based on genotype
probabilities derived using marker genotypes from step 1, creating groups that have a
given pQTL genotype with, e.g,. at least 90% certainty.
4. Randomly split each pQTL genotype group into P subgroups of equal size and
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pool the mRNA of individuals by subgroup. Hybridize mRNA pools to expression arrays
and identify genes that are differentially expressed between pQTL genotypes.
4.2.2 Simulated genome structure
To test the power of pQTL transcriptome mapping, comprehensive data on an F2
cross population were simulated at the genome, transcriptome, and phenome levels. We
will first describe the genome structure of the F2 population: number of chromosomes
and chromosome length, types of QTL, QTL locations and effects, types of DE genes,
and location of DE genes. The problem of simulating the whole genome structure is
complex and computationally intensive. To illustrate the concept of pQTL transcriptome
mapping, we assume that there are two chromosomes (100 cM each), 11 evenly spaced
molecular markers per chromosome (10 cM between adjacent markers) and a few QTL
and DE genes which are randomly located on each chromosome. The types of QTL are
summarized as follows:
pQTL: QTL that do not affect the mRNA expression level but result in a structural
transcript difference of the gene that harbor the pQTL. Trait phenotype is directly
affected by this type of QTL due to a polymorphism at the QTL itself.
peQTL: an eQTL that controls the mRNA expression of certain genes, which in turn
affect the trait phenotype of interest. A peQTL can affect expression of the QTL gene
itself (cis-acting) and/or expression of other genes (trans-acting).
npeQTL : an eQTL that controls the expression of the genes that affect non-trait
phenotypes. A npeQTL can also be cis-acting and/or trans-acting.
Two types of differentially expressed genes (DE genes) are distinguished :
peGenes: DE genes whose expression level are controlled by the corresponding pe-
QTL. peGenes can co-localize with peQTL or away from peQTL.
npeGenes: DE genes that are controlled by the corresponding peQTL npeQTL. npe-
Genes can also co-localize with npeQTL or away from npeQTL.
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Figure 4.2 The genetic map of different QTL and corresponding DE genes.
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The locations of different types of QTL and corresponding DE genes in our simula-
tion are shown in Figure 4.2. Nine DE Genes and five QTL are randomly assigned to
different locations on the two chromosomes. The type of DE genes, eQTL and pQTL
are represented by different symbols. All the DE genes and associated eQTL that are
related to the trait are red or yellow, and those that are not related to the trait are
green. The arrows denote the association between DE genes and their corresponding
eQTL. Chr 1 has one pQTL, one peQTL and one npeQTL, and chr 2 has two peQTL
and two npeQTL. Each eQTL belongs to one of three categories: cis-acting, trans-acting
or both. There is a total four cis-acting and six trans-acting genes, which is consistent
with the fact that trans-acting genes are more common than cis-acting genes (Jansen
and Nap 2004, Pomp et al., 2004, Gibson and Weir 2005). The two QTL at 53cM and
95cM on chr 2 are linked to the pQTL at 73cM on chr 2. They are used to detect how
linkage disequilibrium affects false positive results, i.e., the peGene associated with the
peQTL at 53cM might be falsely associated with peQTL at 73cM due to the linkage dise-
quilibrium. The peGene at 35cM on chr 1 represents a differentially expressed gene that
is associated with multiple eQTL. The peQTL at 73 cM on chr 2 represents an eQTL
that controls multiple genes. Based on the genetic map, QTL genotypes and molecular
marker genotypes were simulated according to the Haldane mapping function.
4.2.3 Simulation models for mRNA expression levels
The mRNA level of differentially expressed genes is simulated as a linear function of
eQTL effects (cis-acting or trans-acting) and biological and technical error (Han et al.,
2004, Lu 2003, Kendziorski et al., 2003 and Shih et al., 2004). The true mRNA level of
the ith gene for the jth individual is denoted by mij and modeled on the log scale as
log(mij) = µi +
T∑
k=1
aik + ²ij, (4.1)
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i = 1, 2, ..., G, j = 1, 2, ..., N and k = 1, 2, ..., T . Here, G is the number of DE genes,
N is the total number of individuals, and T is the total number of eQTL. The quantity
µi represents the mean gene expression level for the i
th gene and aik is the effect of the k
th
eQTL on the expression of the ith gene. We assume that all eQTL are additive. Also, we
assume that aik is on the log scale and contains only additive effects; no dominance effects
are included. The random error ²ij accounts for biological variation, and is assumed to
be independently, identically distributed as N(0, σ2b ), where σ
2
b denotes the biological
variance in gene expression. Then, the observed gene expression level oij on the log
scale is modeled as
log(oij) = log(mij) + ξij, (4.2)
where ξij is technical error which is also assumed to be independently, identically dis-
tributed as N(0, σ2t ). Here, σ
2
t is technical variance introduced in the multiple steps of a
microarray experiment (Chen et al., 2004). Biological and technical errors are assumed
to be independent.
One major step in pQTL transcriptome mapping is to mix the mRNA of randomly
selected individuals to form disjoint pools within genotype groups. Suppose now that
the mRNA from n subjects is combined to form a pool. Let mpij denote true expression
for the ith gene in the jth pool. We assume that the true expression level of a gene in
the mRNA pool is a weighted average of the true expression levels of the gene in all
individuals in the same mRNA pool (Zhang et al. 2006), so that
mpij =
n∑
k=1
(wijk ∗mijk), (4.3)
where
wijk =
zijk
zij1 + zij2 + ....+ zijn
,
i = 1, 2, ..., G, j = 1, 2, ..., P , k = 1, 2, ..., n, where G is the same as defined before, P
is the number of mRNA pools, and n is the number of individuals per mRNA pool such
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that, P∗n = N . When n = 1, the experiment involves no mRNA pooling (a microarray is
made for each individual). The random unobservable weight wijk represents the relative
contribution of individual k to pool j for gene i and is a function of the zijk, which
denote the technical deviations from the ideal pool containing equal amounts of mRNA
from each individual sample. We assume that the zijk are independently, identically
distributed as N(1, σ2z), where σ
2
z denotes the pooling technical variance. If we denote
the observed mRNA level in a pool by opij we can then model it on the log scale as:
log(opij) = log(m
p
ij) + ξij, (4.4)
where ξij is technical error as defined earlier.
4.2.4 Simulation model for phenotypic values
As discussed earlier in Section 4.2.2, phenotypic values of an individual can be af-
fected not only by pQTL, which results in structural transcript difference, but also by
peQTL, which control the mRNA expression of trait related genes. Therefore, we model
the phenotypic values for trait as a linear function of pQTL effect and the true mRNA
expression level of trait-related genes on the log scale. The phenotypic value for the ith
individual, yi, can be modeled as
yi = ν +
S∑
k=1
apQTLk +
G∑
j=1
βj ∗ log(mij) + εi, (4.5)
where i = 1, 2, ..., N. Here, ν is the mean phenotypic value across all the individuals;
S is the total number of pQTL which affect the trait; apQTLk is the effect of the k
th
pQTL on the phenotypic value and we again assume no dominance and no epitasis; βj
is the regression coefficient of phenotypic value on the jth gene’s log expression level,
i.e., the effect of one unit increase in log of gene expression level on phenotype. εi
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is the environmental error and assumed to be independently, identically distributed as
N(0, σ2p), where σ
2
p is the environmental variance.
4.2.5 Statistical models to detect differentially expressed genes
A main objective in transcriptome mapping approaches is to identify the DE genes
which are controlled by the QTL that contributes most to phenotype variation. The
differentially expressed genes that are detected in eQTL transcriptome mapping can be
either trait related or non-trait related. Therefore, we propose implementing a regression
method in the context of an eQTL transcriptome mapping experiment to identify the DE
genes that are trait related and controlled by the most significant phenotype QTL. The
phenotype and marker genotypes are generally known in QTL mapping experiments and
using this marker information we can then predict the location of the most significant
phenotype QTL. In turn, using information on the most significant QTL location and
the nearby marker genotypes, we can predict for each individual the probability of each
genotype at the most significant QTL position (Haley and Knott, 1992). Here, we
propose an F test to find DE genes which are associated with the most significant QTL.
Let pQQi , p
Qq
i p
qq
i be the predicted probabilities of each genotype QQ, Qq and qq for the
ith individual. Then, observed gene expression can be modeled as
log(oij) = µi + β
QQ ∗ pQQi + βQq ∗ pQqi + βqq ∗ pqqi + εi. (4.6)
Here, βQQ, βQq and βqq are regression coefficients to predict the QTL effect of QQ,
Qq and qq genotypes for the most significant QTL; log(oij) is the observed j
th gene
expression level on the ith individual; εi is the random error. Therefore, the test of
βQQ = βQq = βqq can be used to find which genes are control by the significant QTL.
In pQTL transcriptome mapping, we can only observe the expression level for a pool
instead of each individual. Therefore, for the F test in pQTL transcriptome mapping,
log(oij) and pi represent the observed expression level for a pool and the average genotype
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probabilities of all the individuals in the same pool.
The method just described does not only identifies the DE genes controlled by the
most significant QTL but also picks up the DE genes controlled by other QTL due to
linkage disequilibrium. Therefore, also propose an appropriate F-test to implement in
the context of composite interval mapping (Zeng 1994). Composite interval mapping,
in contrast to the standard regression approach, can account for the effect of linkage
disequilibrium. To carry out composite interval mapping, we include not only the QTL
effects in the model, but also the the genotype probabilities of the closest left and right
markers bracketing the interval where the QTL is potentially located. In our simulated
genetic map, these markers are located at 60 and 90 cM on chr 2. Let pMMi,l , p
Mm
i,l ,
pmmi,l , p
MM
i,r , p
Mm
i,r and p
mm
i,r be the left and right marker genotype probabilities for the i
th
individual, respectively. Then the model can be modified as follows
log(oij) = β
QQ ∗ pQQi + βQq ∗ pQqi + βqq ∗ pqqi + βMMl ∗ pMMi,l + βMml ∗ pMmi,l
+βmml ∗ pmmi,l + βMMr ∗ pMMi,r + βMmr ∗ pMmi,r + βmmr ∗ pmmi,r + εi. (4.7)
Here, βMMl , β
Mm
l , β
mm
l , β
MM
r , β
Mm
r , β
mm
r are the QTL effects for the specific left and
right markers. Again, because we assume that mRNA from several individuals is pooled,
we use the p′is and log(oij) to denote the average probabilities and the average expression
level of all the individuals in a pool.
4.3 Results
4.3.1 Simulation results to find the eQTL for differentially expressed gene
in eQTL mapping
An F2 cross population of 500 individuals was simulated at the genome, transcrip-
tome, and phenome levels as described in Sections 4.2.2, 4.2.3 and 4.2.4. QTL genotypes
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and molecular marker genotypes were first simulated based on the genome structure de-
scribed in Figure 4.2. Then, the true and observed mRNA levels on the log scale of
nine DE genes for 500 individuals were simulated according to expressions (4.2) with
σ2b = 0.75
2 and σ2t = 0.25
2. The phenotypic values were also simulated according to
expression (4.5) with σ2p = 2. The associations between DE genes and the corresponding
QTL and parameter values for expressions (4.2) and (4.5) are listed in Table 4.1. In
table 4.1, we simulated data in three different scenarios: QTL being in coupling phase
and small eQTL effect scenario (I), QTL being in coupling phase and large eQTL effect
scenario (II) and QTL being in repulsion phase and small eQTL effect scenario (III).
Note that in Table 4.1, the cis-acting eQTL effects are generally stronger than the trans-
acting eQTL effects as Schadt et al. (2003) suggested. These eQTL account for about
1-10% of total variation at gene expression level. Also note that in the column labeled
“βj” of Table 4.1, the expression of DE genes can either increase (positive β) or decrease
(negative β) the phenotypic trait of interest.
Using individual mRNA expression levels as phenotype, standard interval mapping
was applied to find the corresponding eQTL for the nine DE genes. The results of
Scenario I are shown as an example in Figure 4.3. Note that all the eQTL were correctly
identified for the nine DE genes. Therefore, eQTL transcriptome mapping is effective
to identify the eQTL which control gene differential expression.
4.3.2 Simulation results for pQTL transcriptome mapping
To validate the concept of pQTL transcriptome mapping, we used the same simulated
500 F2 individuals at the genome, transcriptome, and phenome level as described in
Section 4.2.1. We first applied the standard QTL mapping method to the phenotypic
values to find the most significant QTL. Figure 4.4 shows that the phenome QTL is
correctly identified at 73cM on the 2nd chr. Then, for the given pQTL region, We
allocated individuals into three genotype groups (QQ Qq qq) by the most significant
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Figure 4.3 eQTL transcriptome mapping of nine simulated differentially ex-
pressed genes using the standard mapping method (Scenario I).
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QTL genotype based on genotypic probabilities derived using the marker genotypes.
Each genotype group contained only those individuals for whom we could estimate the
pQTL genotype with at least 90% certainty. In that way, we are guaranteed almost
uniform genotypes within each group. The 90% threshold is clearly arbitrary and other
thresholds might also be considered. In our case, about 85% of the individuals satisfied
the inclusion criterion and were included on one of the genotypic groups.
Figure 4.4 Standard QTL mapping to find the most significant phenome
QTL (Scenario I).
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Within these QTL genotype groups, we randomly picked five individuals (n = 5)
to form an mRNA pool. We simulated the true and observed mRNA expression level
on the log scale for all the mRNA pools according to expressions (4.3) and (4.4) with
σ2t = 0.25
2 and σ2z = 0.05
2. Then we used the standard regression method to find the
DE genes whose expression levels were associated with the most significant QTL located
at 73cM on chr 2. We found that four DE genes were significantly associated with the
most significant QTL (0.05 level). Among these four significant genes, three DE genes
(35cM on chr 1, 61cM on chr 2 and 73cM chr 2) were truly associated with the QTL
at 73cM on the 2nd chr and we were expecting to find all three. The fourth DE gene,
however, was a false positive due to linkage disequilibrium, i.e., the DE gene at 72cM
on chr 1 is controlled by the QTL at 53cM on chr 2, which is located close to the most
significant QTL and therefore has a similar QTL genotype.
4.3.3 Empirical power: comparison between pQTL and eQTL transcrip-
tome mapping for identifying trait-related genes
The method of pQTL transcriptome mapping can directly detect trait-related genes.
In contrast, although eQTL transcriptome mapping can successfully detect associations
between differentially expressed genes and the corresponding eQTL, further analyses
need to be performed to pick up the trait-related differentially expressed genes. There-
fore, we used the regression method described in Section 3.2.4 to identify the genes that
were controlled by the most significant QTL in the context of eQTL transcriptome map-
ping and compared the empirical power of that procedure to the power that would be
achieved if pQTL mapping had been applied. Results are shown on the left section of
Table 4.2. We found that in both mapping approaches, the standard regression method
correctly identifies genes 1, 7 and 8, but also frequently identifies genes 4, 5 and 9 which
are not controlled the most significant QTL. These false positive results are due to link-
age disequilibrium. We also noticed that in addition to increasing the chances of false
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positive results, linkage disequilibrium can affect the power of the test within the truly
associated DE genes. For example, in the positively linked (coupling phase) scenario I
and II, the power for gene 1 is very high because this gene is not only controlled by the
most significant QTL, but also is controlled by a QTL at 53cM on chr 2, which is posi-
tively linked to the most significant QTL. However, in scenario III (repulsion phase), the
QTL at 53cM on chr 2 is negatively linked to the most significant QTL and in this case
the power with which we can identify gene 1 drops dramatically. The power that can be
achieved in the pQTL transcriptome mapping approach is generally smaller than in the
eQTL transcriptome mapping approach as we had anticipated. Because gene expression
levels are measured in pooled mRNA samples rather than in individual samples, we have
less information to draw statistical inferences. Note that the power loss is small relative
to the dramatic reduction in the cost of the experiment.
We also estimated the additive effects in the regression approach and the results
corresponding to scenario I are shown for illustration in Table . We found that estimates
of additive effects were biased upwards when the QTL are in a coupling phase (positively
linked) and biased downwards when the QTL are in a repulsive phase (negatively linked).
As can be clearly seen from Table 4.2, the commonly used regression method did
not account for the effect the linkage disequilibrium, which results in biased estimation
of both power and QTL effects. Therefore, we applied the composite mapping method
(Section 4.2.5) to compare the empirical power between eQTL and pQTL transcriptome
mapping for finding the trait-related genes. Results under the three different scenarios
are presented in the right section of Table 4.2. Power is calculated as the percentage
of significant tests at the 0.01 level when testing the hypothesis of gene differential
expression under the most significant QTL (at 73cM chr 2). Within each scenario,
we found that both approaches can correctly identify the DE genes (genes 1, 7 and
8) associated with the most significant QTL. The stronger the QTL effect, the higher
the power to detect the association between QTL and their corresponding DE genes.
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Table 4.3 Comparison of additive effect estimates between eQTL and pQTL
transcriptome mapping by the regression method and composite
method. Entries are the mean (standard deviation) of estimates
over 1000 replicates.
Regression method Composite method
Gene True effect eQTL mapping pQTL mapping eQTL mapping pQTL mapping
1 0.3 0.48 (0.07) 0.48 (0.08) 0.32 (0.17) 0.29 (0.37)
2 0 0.00 (0.07) 0.00 (0.08) -0.01 (0.17) 0.01 (0.37)
3 0 0.01 (0.07) 0.00 (0.09) 0.00 (0.18) -0.02 (0.39)
4 0 0.20 (0.07) 0.20 (0.08) 0.01 (0.17) 0.01 (0.38)
5 0 0.10 (0.07) 0.10 (0.08) 0.01 (0.17) 0.00 (0.38)
6 0 0.00 (0.07) 0.00 (0.08) 0.01 (0.17) 0.01 (0.38)
7 0.3 0.29 (0.07) 0.29 (0.08) 0.31 (0.17) 0.28 (0.37)
8 0.5 0.47 (0.07) 0.48 (0.08) 0.51 (0.17) 0.47 (0.37)
9 0 0.35 (0.07) 0.35 (0.08) 0.00 (0.17) 0.03 (0.38)
Note that the power for pQTL transcriptome mapping is much lower than the power
for eQTL transcript mapping. Further, the power in the composite mapping method is
lower than in the regression method. This might be due to the fact that for composite
mapping we must include the genotypic probabilities of two markers in the model. In
terms of the estimation of QTL effects, we find that the collinearity between the marker
genotype and the predicted QTL genotypic probabilities can be strong in mRNA pools,
which can then increase the standard error of the estimator of QTL effect and thus
mask potentially significant results. We compared the performance of the estimator of
additive QTL effect (Table 4.3) across the two transcriptome mapping approaches and
found that the point estimates of additive effect were similar and unbiased. However,
the precision with which we can estimate additive QTL effects is higher in the eQTL
transcriptome mapping approach.
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4.4 Discussion
Through simulation, we have shown that pQTL transcriptome mapping is an effective
method to find differentially expressed genes controlled by trait QTL. Although the
power of pQTL mapping is lower than the power of eQTL and point estimates of QTL
effect sizes are less precise, the lower cost of a pQTL experiment may still justify its use.
Therefore, there is a trade-off between power,precision and cost. If the objective of an
experiment is to pin-point the most significant trait-related genes and not to identify
all the trait-related genes, then pQTL mapping can be an efficient and cost saving
alternative. The differentially expressed genes (pQTL DE-genes) identified in the pQTL
mapping approach may potentially be genes involved in pathways that are controlled by
the pQTL (pQTL pathway genes). Based on map location, they can be grouped into
those that are located inside (internal pQTL DE-genes) and outside (external pQTL
DE-genes) the pQTL region. Internal pQTL DE-genes can become important candidate
genes for the pQTL and might be included in further experimentation.
Many factors can affect the power of pQTL transcriptome mapping approaches.
Those include the population size, the marker density, the effect and position of pQTL
and eQTL, the interaction between the different QTL, the correlation between expression
level and phenotypic value, the biological and technical variances, the pooling technical
variation at the transcription level and the environmental variation at the phenome level
and the mRNA pooling strategy. The population size, marker density, the effect and
position of pQTL and eQTL,the correlation between expression level and phenotypic
value and the environmental variability at the phenome level play a main role in the
prediction of phenome QTL location (Step 1 and 2 in pQTL transcriptome approach).
For a given phenome QTL location, the prediction of genotype probability will depend
on marker density and cut-off criteria (Step 3 pQTL transcriptome approach). Based
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on the mRNA pools of grouped individuals, the statistical analysis for identifying trait-
related genes can be affected by the effect and position of pQTL and eQTL, the effect of
the biological and technical variances, the pooling technical variation at the transcrip-
tion level and the pooling strategy (Step 4 in pQTL transcriptome mapping). In an
experiment, the marker density, the effect and position of pQTL and eQTL, interaction
between the QTL, the correlation between expression level and phenotypic value, the
biological and technical variance, the pooling technical variation at the transcription
level and the environmental variation at the phenome level are fixed and cannot be
changed by the researcher. Therefore, the mRNA pooling strategy, under the control of
the researcher, might be one determinant of the power that can be achieved in a pQTL
transcriptome mapping experiment. The strategy for pooling mRNA involves the choice
of the number of pools and of the size of each pool. Several researchers (Kendziorski et
al., 2003, Shih et al., 2004, Zhang et al., 2006) have investigated the effect of pooling
mRNA on power in microarray experiments. They argue that pooling mRNA from a few
similar individuals when conducting microarray experiments is feasible and this further
supports the concept of the pQTL mapping approach.
We applied two methods to identify trait-related differentially expressed genes in the
context of eQTL and pQTL transcriptome mapping approaches. In the commonly used
regression method, linkage disequilibrium results in false detection of pQTL pathway
genes. The larger the QTL effects and the stronger the linkage disequilibrium, the
higher the false positive rate. Further, the regression method for estimating QTL effects
can result in biases whose directions depend on whether the QTL are in coupling or
repulsive phase. Therefore, we propose that the composite mapping method is a more
reliable alternative for identifying DE genes which are associated with a given QTL. To
carry out the composite mapping approach, we include QTL genotype and the genotype
of the left and right markers bracketing the putative QTL location in the statistical
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model. In this way, our analysis accounts for the effect of linkage disequilibrium and
avoids the false positive results. Further, it results in unbiased estimates of QTL effects.
Note that linkage disequilibrium can also be overcome by using advanced intercross lines
as the resource population since these can have less extensive linkage disequilibrium.
One major step in pQTL transcriptome mapping is the prediction of the genotype of
all the individuals assuming a QTL location (step 3). The prediction of QTL genotype
may depend on the QTL location, the location of nearby markers and the distance of
the given QTL location to the nearby markers. If individuals have not been correctly
genotyped, this can severely affect the power of the test. In this work, we assigned
individuals to a genotype group only if the predicted QTL genotype had probability
higher than 90%. Using this criterion, we eliminated about 15% of the individuals from
the study. To further investigate the reliability with which we had grouped individuals
with equal genotype at the QTL, we compared the predicted QTL genotype with the
true QTL genotype and found at least 95% similarity, i.e., we had at least 95% certainty
that individuals in the same group had uniform genotype. Therefore, uncertainty about
the true genotype at the QTL did not significantly affect the observed power in our
simulation study. If the cut-off criterion is lowered, more individual will be kept in the
analysis. However, the pools within each genotype group may no longer be uniform and
this may result in lower statistical power.
The pQTL transcriptome mapping is proposed under the assumption that there is one
major QTL and that the individuals are grouped according to this major QTL genotype.
If there are several QTL with moderate effect, different genotypic groups may be created
for the multiple pQTL to investigate the main effects and the interactions between pQTL.
Further, pQTL transcriptome mapping focuses only on a single phenotypic trait. The
same type of analysis can be carried out if other traits are of interest, and would likely
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involve different pQTL.
Clearly, eQTL transcriptome mapping can provide a wealth of information on the
genetic control of transcriptome variation. However, a large proportion of the differen-
tially expressed genes and their associated eQTL will not be relevant to the phenotypic
traits of interest. Instead, they will affect what are referred to as non-trait phenotypes.
Identification of relevant expression differences requires additional analyses to connect
transcriptome variation to pQTL genotypes. In contrast, the proposed pQTL approach
directly pinpoints differentially expressed genes associated with the phenotypic traits of
interest.
Overall, the pQTL transcriptome mapping approach is a valid method to explore the
genetic architecture of traits of interest. Because an erosion of the power of statistical
tests is inevitable, the pQTL transcriptome mapping approach can be a good choice if
the main interest is to identify only the most significant differentially expressed genes
in the regulatory pathway. The benefits of implementing the pQTL rather than the
eQTL approach include a large reduction in the cost of experimentation and also in the
amount of data to be analyzed because pQTL only generates expression data relevant
to the trait(s) of interest.
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CHAPTER 5. DISCUSSION
Microarrays are powerful tools to simultaneously measure the mRNA expression lev-
els of thousands of genes and are widely applied to study complex biological problems at
the genetic level. In such experiments, mRNA from individuals is sometimes pooled and
the microarray is then obtained for the pool rather than for each individual. Pooling
mRNA is the strategy adopted when the cost of individual microarrays is prohibitive or
when the amount of mRNA available for each individual is not sufficient. While pooling
mRNA for analyses can be an enabling strategy, questions arise about the loss of infor-
mation incurred when pooling mRNA from a group of individuals. In this dissertation,
we investigate the impact of pooling mRNA on different types of inferences that might
be drawn from microarray and QTL mapping experiments.
More precisely we focus on the following questions:
1. What is an appropriate statistical model to represent observed gene expression in
a pool of mRNA samples?
2. If we are interested in identifying genes with differential expression under different
conditions or treatments, to what extent will pooling mRNA result in a loss of
power of the appropriate statistical tests?
3. When designing a microarray experiment that involves pooling mRNA, which pool-
ing strategies result in inferences that better approximate what might have been
discovered using individual mRNA samples?
101
4. Suppose that we have measurements on some phenotypic trait for all individuals
in an experiment, but that we have measured gene expression only in pools formed
by mixing mRNA from various individuals. How do we estimate the correlation
between gene expression and phenotype in that case?
5. What pooling strategy would result in an estimate of the correlation coefficient
with smaller bias and root mean squared error?
6. Finally, if the objective of the experiment is to find genes whose expressions are
associated with one or more QTL, can we achieve acceptable statistical power if
we pool mRNA samples?
We addressed questions 1 - 3 in Chapter 2 of the dissertation. Questions 4 and 5
were the subject of Chapter 3. Finally, in Chapter 4 we discussed the impact of pooling
mRNA on power with which we can identify genes whose expressions were associated
with one or more QTL.
In Chapter 2 we proposed a realistic statistical model for observed gene expression
level in a pool. The model mimicked the mRNA pooling process in that it recognized
that mRNA is pooled in the original, untransformed scale and that the mRNA contri-
butions from each individual to the pool might not be exactly equal. Under that model,
we developed the appropriate F test to identify differentially expressed genes. Via sim-
ulation, we showed that the power derived under our proposed model was conservative
and close to the true power. In this sense, our approach performed better than other
approaches that had been proposed in the literature. The simulation experiment was
designed to permit investigating the effects of the number of pools, the number of indi-
viduals per pool, the number of measurements of each pool obtained in the experiment,
the effect size, and the relative sizes of the biological and technical variances on the
power of the appropriate F-test. We found that obtaining replicate measurements from
each pool had negligible effect on power. We also found that for large enough effect sizes,
102
it was possible to design an experiment based on pooling mRNA samples that almost
achieves the power that would be obtained when arraying individual mRNA samples.
Thus, we argued that under certain conditions, pooling mRNA samples could be a good
strategy if cost is a consideration.
In Chapter 3 we again investigated the effect of pooling mRNA, but this time focused
on the accuracy and reliability with which we can identify genes whose transcript abun-
dance is correlated with phenotype for a quantitative trait. Here, we considered two
different pooling strategies: mRNA pools are randomly created (random pool design) or
individuals are first stratified by phenotype and phenotypically similar individuals are
allocated to the same pool (stratified pool design). We found that the commonly used
Pearson correlation estimator worked well in the random pool design but was biased
in the stratified pool design. Therefore, we proposed a maximum likelihood estimator
(MLE) to estimate the correlation between genes transcript abundance and phenotypic
trait under the two pooling strategies. Using a simulation study, we showed that the
MLE and the Pearson product-moment correlation estimates perform equally well when
individuals are randomly allocated to pools. The MLE estimate is superior to the Pear-
son product-moment correlation estimate (in the sense that it has smaller bias) when
individuals are allocated to pools according to their phenotypic value. Furthermore,
once an MLE has been obtained, it can be used in a likelihood ratio test to determine
whether gene expression level is correlated with phenotype. We showed that the em-
pirical power in the likelihood ratio test is the same as in a permutation test and as in
the usual test based on Fisher’s z-transformation of the correlation coefficient. We also
showed that power is generally higher for the stratified pool design than for the random
pool design. Therefore, if mRNA must be pooled, creating the pools by mixing mRNA
of individuals with similar phenotype and then estimating the correlation between gene
expression and phenotype using ML can be a reasonable strategy.
In Chapter 4, we explored the consequences of pooling mRNA if we wish to identify
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genes whose expression levels are controlled by a QTL of interest. Recently, an approach
known as eQTL transcriptome mapping was proposed and is being applied today in many
species. The eQTL methodology combines quantitative trait locus (QTL) mapping with
gene expression analysis and permits investigating the genetic regulatory pathways at
the mRNA level. However, the high cost of performing individual microarrays for eQTL
transcriptome mapping limits sample sizes and consequently, the power of tests used
to identify trait or pathway related genes. Therefore, we investigated whether pooling
mRNA might be a viable alternative in this type of experiment. A methodology denoted
as pQTL transcriptome mapping was recently proposed (Cabrera et al., 2006), in which
individuals are allocated to a pool according to their QTL genotype. Gene expression
levels are then measured in the mRNA pools. To assess the performance of the pQTL
approach in terms of statistical power, we simulated an intercross F2 population at
the genome, transcriptome and phenome levels. We implemented the eQTL and pQTL
approaches on the simulated populations and compared the empirical power for the two
methods. In the commonly used regression method, the power of pQTL transcriptome
mapping is lower but comparable to eQTL transcriptome mapping. However, linkage
disequilibrium results in false detection of pQTL pathway genes and biased estimation of
QTL effects, whose directions depend on whether the QTL are in coupling or repulsive
phase. The composite method accounts for the effect of linkage disequilibrium and
results in unbiased estimates of QTL effects. However, pooling mRNA results in a loss
of power when compared to eQTL transcriptome mapping and the point estimates of
QTL effects are less precise. Although there might be a substantial loss in power, pooling
mRNA is clearly advantageous from an economic point of view. We concluded that if the
objective of an experiment is to pinpoint only the most significant trait-related genes,
pQTL mapping is a cost-effective approach.
Clearly, carrying out microarray experiments using individual mRNA samples is
always the best strategy in terms of the accuracy and reliability with which we can
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estimate quantities or associations of interest. This is likely due to the effect of larger
number of individuals. However, as suggested by the results we have obtained, it is
possible to design an experiment that involves mRNA pooling and that can dramatically
reduce the cost of experimentation while still achieving acceptable power or precision.
It is not possible to recommend a single design that would perform equally well in all
situations. Instead, we have tried to describe the factors which contribute to greater
power or precision when mRNA must be pooled in the three experimental scenarios on
which we have focused in this work. When considering whether to pool the mRNA
from various individuals, the research should understand the trade off between power,
precision and cost, and be able to choose a suitable design according to the research
objectives, the lab resources and cost constraints.
When the number of individuals that can be included in an experiment is fixed,
constructing as many pools as possible within the total sample size constraint appears
to be the best approach. For example, by pooling individuals in pairs, it is possible to
reduce the cost of experimentation by half while minimizing the reduction in degrees of
freedom. We showed in Chapter 2 that it is possible to achieve adequate power for any
effect size when the pool sizes is small and the number of pools is large. A similar result
was obtained in Chapter 3, where we showed, via simulation studies, that in order to
estimate the correlation between phenotype and gene expression, an important factor is
the number of degrees of freedom (in our case, the number of pools) that can be used
in calculations. Thus, in general it appears to be important to include as many pools in
the design of the experiment as the experimental budget will allow.
One major assumption in the experiments involving mRNA pooling is that the gene
expression level of a mRNA pool is close to the average gene expression of all the
individuals in the pool. To investigate whether this is a plausible assumption, we cannot
rely on simulated data but must instead carry out a laboratory experiment in which
gene expression is measured both at the individual level and also on pools created by
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mixing mRNA samples. Several experiments (Kendziorski et al. 2005 and Shih et
al. 2004) have been carried out to investigate the validity of the assumption. However,
they compared measurements obtained from mRNA pools with individual measurements
on a normalized scale, which assumes that pooling mRNA can accomplished on the
transformed scale. As we argued in Chapter 2 of this dissertation, this assumption
cannot be justified. If the assumption holds on the original scale, then gene expression
measurements from the pools would be highly correlated with the average expression
measurements obtained from individuals in the pools. We would also expect to observe
approximately the same set of differentially expressed genes whether measurements are
taken from pools or from individuals. It is important to realize, however, that the
degree of correlation between individual and pool measurements will depend on the
relative size of the pooling technical error variance, which reflects the accuracy with
which the pool is constructed. For example, while we assume that equal amounts of
mRNA are contributed by each individual in the pool, in practice this assumption is
likely to be violated. If pools are likely to contain very different amounts of mRNA from
each member, then the statistical models and analyses should be extended to better
reflect the process of pooling mRNA.
In our work, we discussed the pQTL transcriptome mapping approach assuming that
the mRNA pools are formed by randomly grouping individuals within a QTL genotype.
Under that pooling strategy we implemented both a regression method and a composite
mapping method to identify the genes in the pathway of the trait. A next step would be
to extend the concept of stratified pools into the pQTL transcriptome mapping method-
ology. For example, we could think about stratifying individuals according to phenotypic
values within each genotype class and then pooling the mRNA from similar individuals.
It would be interesting to investigate the effect of stratifying individuals to construct
pools on the precision with which we can estimate QTL effects and on the power of
the appropriate statistical test. Given that stratifying individuals by phenotypic value
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was advantageous when interest centers in estimating the correlation between gene ex-
pression and phenotype, we speculate that the appropriate stratification strategy might
also result in more reliable inference within the context of pQTL mapping. Investigating
whether this is in fact true would permit deciding which pooling strategy is better suited
to the estimation of QTL locations and effect sizes and to identifying trait-related genes.
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